AU2012299397A1 - Fracturing process to enhance propping agent distribution to maximize connectivity between the formation and the wellbore - Google Patents

Abstract

A method of treating a subterranean formation may include placing a first treatment fluid into a subterranean formation through an access conduit connecting the subterranean formation to a wellbore at a pressure sufficient to form at least a portion of a fracture network; pumping a second treatment fluid comprising a propping agent into the fracture network such that the propping agent forms a proppant pack in at least a portion of the fracture network; placing a third treatment fluid comprising a secondary diverting agent into the fracture network so as to substantially inhibit fluid flow through at least a portion of the fracture network without substantially inhibiting fluid flow through the access conduit; and placing a fourth treatment fluid comprising a primary diverting agent into the wellbore such that the primary diverting agent substantially inhibits fluid flow through the access conduit.

Description

WO 2013/028298 PCT/US2012/047787 FRACTURING PROCESS TO ENHANCE PROPPING AGENT DISTRIBUTION TO MAXIMIZE CONNECTIVITY BETWEEN THE FORMATION AND THE WELLBORE 5 BACKGROUND [0001] The present invention relates generally to enhancing propping agent distribution in order to maximize connectivity between a subterranean formation and a wellbore so as to improve production from a subterranean 10 formation. [0002] After a welibore is drilled, it may often be necessary to fracture the subterranean formation to enhance hydrocarbon production, especially in shale formations that typically have high closure stresses. Access to the subterranean formation can be achieved by first creating an access conduit from 15 the wellbore to the subterranean formation. Then, a fracturing fluid, called a pad, is introduced at pressures exceeding those required to maintain matrix flow in the formation permeability to create or enhance at least one fracture that propagates from at least one access conduit. The pad fluid is followed by a fluid comprising a propping agent to prop the fracture open after pressure is reduced. 20 In some formations like shales, fractures can further branch into small fractures extending from a primary fracture giving depth and breadth to the fracture network created in the subterranean formation. As used herein, a "fracture network" refers to the access conduits, fractures, microfractures, and/or branches, man-made or otherwise, within a subterranean formation that are in 25 fluid communication with the welibore. The propping agents hold open the fracture network thereby maintaining the ability for fluid to flow through the fracture network to ultimately be produced at the surface. [0003] Distribution of the propping agents is an important factor to maximizing production from the fracture network. Propping agents, like the fluid 30 in which they are suspended, follow the path of least resistance, which in practice is typically into only a small percentage of fractures that have been created, and most definitely not into an appreciable number of branches that extend therefrom. Heterogeneous distribution of propping agents within a fracture network often yields a production curve with shorter steady state 35 production and steep production decline, shown in Figure la, i.e., the formation produces hydrocarbon for a shorter amount of time and production decline is 1 WO 2013/028298 PCT/US2012/047787 very rapid. This is most often observed in shale and other very low permeability formations. Recovering a well after production decline typically involves refracturing, which can be costly and time consuming. [0004] To provide a more uniform distribution of propping agents in the 5 entire fracture network to maximize production potential, some form of diversion within or among zones in the subterranean formation may be useful. For example, a packer or bridge plug may be used between sets of access conduits to divert a treatment fluid between the access conduits. Also, sand may be used as diverting agents to plug or bridge an access conduit. In another technique, 10 balls, commonly referred to as "perf balls," may be used to seal off individual access conduits to divert fluid, and consequently propping agents, to other access conduits. Such techniques may be only partially successful towards uniform distribution of propping agents, especially in dendritic and shattered fracture networks, because they only address the distribution issues at the 15 wellbore, i.e., at the access conduit, not within the highly interconnected, multi branched fracture network. [0005] One of many problems in the use of some or all of the above described procedures may be that the means of diverting the treatment fluid requires an additional step of removing it from the wellbore to allow the 20 maximum flow of produced hydrocarbon from the subterranean zone into the wellbore. For example, a bridge plug generally is removed or drilled out at the end of the operation to allow for production. Similarly, sand plugs or bridges are cleaned out for production; sealing balls are often recovered for production, both of which incur additional time and expenses. 25 [0006] Particulate diverting agents may be difficult to remove completely from the subterranean formation, which may cause a residue to remain in the wellbore area following the fracturing operation, which may permanently reduce the permeability of the formation. In some cases, difficulty in removing conventional diverting agents from the formation may permanently 30 reduce the permeability of the formation by between 5% to 40%, and may even cause a 100% permanent reduction in permeability in some instances. [0007] Additionally, when the wellbore to be treated is a highly deviated wellbore, traditional sand plugs are thought to be ineffective at isolating zones along the highly deviated weilbore because they may fail to fully plug the 35 diameter of the wellbore. As used herein, the term "deviated wellbore" refers to 2 WO 2013/028298 PCT/US2012/047787 a wellbore in which any portion of the well is in excess of about 55-degrees from a vertical inclination. As used herein, the term "highly deviated wellbore" refers to a wellbore that is oriented between 75-degrees and 90-degrees off-vertical (wherein 90--degrees off-vertical corresponds to a fully horizontal wellbore). 5 That is, the term "highly deviated welibore" may refer to a portion of a wellbore that is anywhere from fully horizontal (90--degrees off-vertical) to 75--degrees off-vertical. SUMMARY OF THE INVENTION [0008] The present invention relates generally to enhancing propping 10 agent distribution in order to maximize connectivity between a subterranean formation and a wellbore so as to improve production from a subterranean formation. [0009] In some embodiments, the present invention provides a method that comprises: providing a wellbore penetrating a subterranean formation, 15 wherein the subterranean formation is able to support a fracture network; providing at least one access conduit to the subterranean formation from the wellbore; placing a first treatment fluid into the subterranean formation through the at least one access conduit at a pressure sufficient to form at least a portion of a fracture network extending from the at least one access conduit; pumping a 20 second treatment fluid comprising a propping agent into the fracture network such that the propping agent forms a proppant pack in at least a portion of the fracture network; placing a third treatment fluid comprising a secondary diverting agent into the welibore such that the secondary diverting agent goes through the access conduit and into at least a portion of the fracture network so 25 as to substantially inhibit fluid flow through at least a portion of the fracture network without substantially inhibiting fluid flow through the access conduit; and placing a fourth treatment fluid comprising a primary diverting agent into the wellbore such that the primary diverting agent substantially inhibits fluid flow through the access conduit 3.0 [0010] In some embodiments, the present invention provides a method that comprises: providing a weilbore penetrating a subterranean formation, wherein the subterranean formation has a closure pressure greater than about 500 psi; providing at least one access conduit to the subterranean formation from the wellbore; placing a first treatment fluid into the subterranean formation 35 through the at least one access conduit at a pressure sufficient to form at least a 3 WO 2013/028298 PCT/US2012/047787 portion of a fracture network extending from the at least one access conduit; pumping a second treatment fluid comprising a propping agent into the fracture network such that the propping agent forms a proppant pack in at least a portion of the fracture network; placing a third treatment fluid comprising a secondary 5 diverting agent into the wellbore such that the secondary diverting agent goes through the access conduit and into at least a portion of the fracture network so as to substantially inhibit fluid flow through at least a portion of the fracture network without substantially inhibiting fluid flow through the access conduit; and placing a fourth treatment fluid comprising a primary diverting agent into 10 the wellbore such that the primary diverting agent substantially inhibits fluid flow through the access conduit. [0011] In some embodiments, the present invention provides a method that comprises: providing a wellbore penetrating a subterranean formation, wherein the subterranean formation is able to support a fracture network and 15 the wellbore has at least one access conduit to the subterranean formation from the wellbore; placing a first treatment fluid into the subterranean formation at a pressure sufficient to form at least a portion of a fracture network extending from at least one access conduit; pumping a second treatment fluid comprising a propping agent into the fracture network such that the propping agent forms a 20 proppant pack in at least a portion of the fracture network, wherein the propping agent comprises proppant particulates at least partially coated with a consolidating agent and at least a portion of degradable particles; placing a third treatment fluid comprising a secondary diverting agent into the wellbore such that the secondary diverting agent goes through the access conduit and into at 25 least a portion of the fracture network so as to substantially inhibit fluid flow through at least a portion of the fracture network without substantially inhibiting fluid flow through the access conduit, wherein the secondary diverting agent is at least partially degradable; placing a fourth treatment fluid comprising a primary diverting agent into the wellbore such that the primary diverting agent 30 substantially inhibits fluid flow through the access conduit, wherein the primary diverting agent is at least partially degradable; and repeating at least one step selected from the group consisting of pumping the second treatment fluid, placing the third treatment fluid, placing the fourth treatment fluid, placing the fifth treatment fluid, and any combination thereof. 4 WO 2013/028298 PCT/US2012/047787 [0012] The features and advantages of the present invention will be readily apparent to those skilled in the art upon a reading of the description of the preferred embodiments that follows. BRIEF DESCRIPTION OF THE DRAWINGS 5 [0013] The following figures are included to illustrate certain aspects of the present invention, and should not be viewed as exclusive embodiments. The subject matter disclosed is capable of considerable modification, alteration, and equivalents in form and function, as will occur to those skilled in the art and having the benefit of this disclosure. 10 [0014] Figures la-b illustrate the production curve of a subterranean formation based on distribution of propping agents. [0015] Figure 2 illustrates the placement of elements within a dendritic fracture network. [0016] Figure 3 illustrates the placement of elements within a shattered 15 fracture network. [0017] Figure 4 illustrates a nonlimiting example of a fracture network response to a method of the present invention. [0018] Figure 5 illustrates a nonlirniting example of wellbore pressure during a method of the present invention. 2 0 DETAILED DESCRIPTION [0019] The present invention relates generally to enhancing propping agent distribution in order to maximize connectivity between a subterranean formation and a wellbore so as to improve production from a subterranean formation. 25 [0020] The methods of the present invention provide for the systematic introduction of a series of diverting agents that enhances the uniform distribution of propping agents through a fracture network. In brittle formations, like shale, a fracture network may comprise access conduits, fractures, microfractures, and branches. As used herein, an "access conduit" refers to a 30 passageway that provides fluid communication between the wellbore and the subterranean formation, which may include, but not be limited to, sliding sleeves, open holes in non-cased areas, hydrajetted holes, holes in the casing, perforations, and the like. The methods of the present invention provide for treatment fluid and propping agent diversion in at least each of these fracture 35 network components. Uniform distribution of propping agents maximizes the 5 WO 2013/028298 PCT/US2012/047787 connectivity between the formation and the wellbore, thereby maximizing hydrocarbon production therefrom. Further, the diversion methods provided herein better dilate the branches that give depth and breadth to a fracture network. Without being bound by theory, it is believed that dilated components 5 of a fracture network more readily incorporate propping agents, which consequently yields more hydrocarbon in production operations. These methods may be particularly useful in deviated wellbores that are notorious for heterogeneous distribution of propping agents and heterogeneous fracture network dilation. 10 [0021] Uniform distribution of propping agents allows for the use of less overall propping agents, thereby reducing the cost of the operation. As depicted in the comparison of Figure 1, uniform distribution of propping agents (Figure 1b) rnay extend the lifetime of a well by increasing the length of the steady state production and reducing the rate of production decline, as compared to 15 heterogeneous propping agent distribution (Figure la). [0022] Further advantageously, some embodiments may include some combination of the various diverting agents being degradable. Degradable diverting agents decrease, and may eliminate, the need for secondary operations to restore fluid conductivity within the fracture network when production 20 operations begin, which consequently reduces the environmental impact of subterranean operations. This reduces the cost and time for fracturing operations. [0023] In some methods of the present invention, any combination of propping agents, a primary diverting agent, a secondary diverting agent, and 25 optionally a degradable particle may be introduced via a treatment fluid into a wellbore penetrating a subterranean formation. In some embodiments, the elements of a propping agent, a primary diverting agent, a secondary diverting agent, and optionally a degradable particle may be introduced into a wellbore via a single treatment fluid comprising all of the elements, individual treatment 30 fluids comprising a single element, a plurality of treatment fluids comprising some combination of at least two of the elements, and any combination thereof. As used herein, the term "treatment," or "treating," refers to any subterranean operation that uses a fluid in conjunction with a desired function and/or for a desired purpose. The term "treatment," or "treating," does not imply any 35 particular action by the fluid. 6 WO 2013/028298 PCT/US2012/047787 [0024] As used herein, a "diverting agent" refers to any material that can be used to substantially seal off a portion of a subterranean formation thereby substantially reducing, including blocking, fluid flow therethrough. As used herein, a "primary diverting agent" refers to a diverting agent that 5 substantially inhibits fluid flow through an access conduit. As used herein, a "secondary diverting agent" refers to a diverting agent that substantially inhibits fluid flow through at least a portion of the fracture network. Suitable diverting agents may comprise gels, particles, and/or fibers that are natural or synthetic; degradable or nondegradable; and mixtures thereof. Nonlirniting examples of 10 suitable diverting agents are included below. [0025] As used herein, "propping agents" refers to any material or formulation that can be used to hold open at least a portion of a fracture network. As used herein, a "proppant pack" is the collection of propping agents in a fracture network. 15 [0026] As used herein, a "degradable particle," and derivatives thereof, refers to any material that can be used in conjunction with a proppant pack that when substantially degraded leaves a void in the proppant pack. It should be understood that the term "particulate" or "particle," and derivatives thereof as used in this disclosure, includes all known shapes of materials, including 20 substantially spherical materials, low to high aspect ratio materials, fibrous materials, polygonal materials (such as cubic materials), and mixtures thereof. As used herein, the terms 'degradation" or "degradable" refer to both the two relatively extreme cases of hydrolytic degradation that the degradabler material may undergo, e.g., heterogeneous (or bulk erosion) and homogeneous (or 25 surface erosion), and any stage of degradation in between these two. This degradation can be a result of, inter alia, a chemical or thermal reaction, or a reaction induced by radiation. Nonlimiting examples of degradable particles are included below. [0027] It should be noted that when "about" is provided at the 30 beginning of a numerical list, "about" modifies each number of the numerical list. It should be noted that in some numerical listings of ranges, some lower limits listed may be greater than some upper limits listed. One skilled in the art will recognize that the selected subset will require the selection of an upper limit in excess of the selected lower limit. 7 WO 2013/028298 PCT/US2012/047787 [0028] In some embodiments, at least one access conduit from the wellbore to the subterranean formation may be created. In some embodiments, at least one access conduit from the wellbore to the subterranean formation may be provided. These access conduits may be made by any means or technique 5 known in the art including, but not limited to, hydrajetting; laser inscribing; perforating; not casing at least a portion of the wellbore, and the like. Suitable examples of perforation tools and methods may include, but not be limited to, those disclosed in U.S. Patent Numbers 5,398.760; 5,701,957; 6,435,278; 7,159,660; 7,172,023; 7,225,869; 7,303,017; and 7,841,396, the entirety of 10 which are incorporated herein by reference. Access conduits may be spaced randomly, spaced substantially equidistant from each other, clustered in groups (e.g., an access conduit cluster), or any combination thereof along the length of the wellbore. [0029] In some embodiments, a treatment fluid may be introduced into 15 a wellbore at a pressure sufficient to form at least one fracture extending from at least one access conduit into a subterranean formation. In some embodiments, the pressure may be sufficient to form at least one branch extending from at least one fracture. In some embodiments, the pressure may be sufficient to form a fracture network. In some embodiments, the pressure 20 may be sufficient to form at least a portion of a fracture network. In some embodiments, a fracture network may comprise access conduits, fractures, microfractures, branches, or any combination thereof including those which are natural and man-rmade. In some embodiments, a fracture network may be considered a dendritic fracture network, a shattered fracture network, or any 25 combination thereof. Figure 2 illustrates a nonlimiting example of a dendritic fracture network extending from a wellbore into a subterranean formation. Figure 3 illustrates a nonlimiting example of a shattered fracture network extending from a wellbore into a subterranean formation. These nonlimiting examples illustrate two types of fracture networks extending from a horizontal 30 well. It should be understood that the methods provided herein are applicable to wellbores at any angle including, but not limited to, vertical wells, deviated wells, highly deviated wells, horizontal wells, and hybrid wells comprising sections of any combination of the aforementioned wells. In some embodiments, a subterranean formation and wellbore may be provided with an 35 existing fracture network. 8 WO 2013/028298 PCT/US2012/047787 [0030] In some methods of the present invention, any single or combination of elements including propping agents, a primary diverting agent, a secondary diverting agent, and a degradable particle may be placed via a treatment fluid into a welibore penetrating a subterranean formation. It should 5 be noted that placing may include pumping, introducing, adding, injecting, inserting, and the like. [0031] Some embodiments of the present invention may include the following steps: (a) placing a first treatment fluid into a wellbore at a pressure 10 sufficient to create or enhance at least a portion of a fracture network; (b) placing a second treatment fluid comprising propping agents into a welibore; (c) placing a third treatment fluid comprising a secondary diverting agent into the wellbore; 15 (d) placing a fourth treatment fluid comprising a primary diverting agent into the wellbore; and (e) optionally placing a fifth treatment fluid comprising a degradable particulate into the wellbore. [0032] It should be noted that the number modifiers, i.e., first, second, 20 third, fourth, and fifth, do not necessarily indicate an order of placement or differences in composition. They are only meant to differentiate between treatment fluids. In some embodiments, a method of treating a subterranean formation may comprise either step c or step d listed above. [0033] As described above and illustrated in Figure 2, a primary 25 diverting agent may substantially inhibit fluid flow through an access conduit and/or divert fluid flow to another access conduit. A secondary diverting agent may substantially inhibit fluid flow within the fracture network, e.g., through a fracture and/or a branch so as to divert fluid flow to branches extending from the fracture. A degradable particle may incorporate into a proppant pack such 30 that when substantially degraded a void in the proppant pack is produced. [0034] In some embodiments, the steps provided above rnay be performed in order. In some embodiments, one or more steps rnay be performed more than once. In some embodiments, one or more steps may be performed simultaneously. In some embodiments, the steps provided above 9 WO 2013/028298 PCT/US2012/047787 may be performed in any order. Nonlimiting examples of methods of the present invention may include the following: (1) a - b - b/c - b/e - b/c/e - b/d - b/c - b/e - b/c - b/e - b/c/e; (2) a/b - c(-c/e - b - c -- b - d -- b - b/c/e -- b - b/d -- b/c -b 5 and (3) a/b/e -- b/e -- b/c - b/e -- b -- b/e - b/c - b -- b/d -- b/c/e -- b/c. It should be noted that performing two steps simultaneously, i.e., b/c, indicates that the second treatment fluid and the third treatment fluid are one in the same. Other combinations may also be suitable. 10 [0035] The diversion methods of the present invention may provide for better dilation of the components of the fracture network, which enhances hydrocarbon production. By way of nonlirniting exarnple, Figure 4 illustrates the dilation (line thickening) of a fracture network as the steps of b/e - b/c - b/c b/d - b/e - b/c are performed on an already fractured subterranean formation 15 (propping agents not shown, only dilation progression). [0036] In some embodiments, the amount of an element within a treatment fluid may vary during a step. By way of nonlimiting example, the introduction of propping agents in a treatment fluid may be at 30 pounds per gallon ("ppg") when the step begins then reduce to 10 ppg when the end of the 20 step is complete. In some embodiments, changing the amount of an element in a treatment fluid may be an increase or decrease as a stepwise change, a gradient change, or any combination thereof. In some embodiments where multiple elements are introduced simultaneously, the amount of one or more elements may change during the step. 25 [0037] In some embodiments, the amount of element(s) may stay constant while the amount of other additive(s), including those described below, are changed. In some embodiments, both the amount of element(s) and additive(s) may change within a step. [0038] In some embodiments, the methods of the present invention 30 optionally may comprise monitoring the flow of one or more treatment fluids in at least a portion of the subterranean formation during all or part of a method of the present invention. Monitoring may, for example, ensure a primary and/or secondary diverting material are being placed appropriately within the fracture network, determine the presence or absence of a primary and/or secondary 35 diverting material in the fracture network, and/or determine whether a primary 10 WO 2013/028298 PCT/US2012/047787 and/or secondary diverting material actually diverts fluids introduced into the subterranean formation. Monitoring may be accomplished by any technique or combination of techniques known in the art. In certain embodiments, this may be accomplished by monitoring the fluid pressure at the surface of a welibore 5 penetrating the subterranean formation where fluids are introduced. For example, if the fluid pressure at the surface increases, this may indicate that the fluid is being diverted within the fracture network. Additionally, a pressure decrease or substantially steady-state pressure may indicate a portion of the fracture network is dilating. Pressure monitoring techniques may include various 10 logging techniques and/or computerized fluid tracking techniques known in the art that are capable of monitoring fluid flow. Examples of commercially available services involving surface fluid pressure sensing that may be suitable for use in the methods of the present invention include those available under the tradename EZ-GAUGE (surface pressure sensing tools, available from 15 Halliburton Energy Services, Inc., Duncan, OK). [0039] It should be noted that fluid pressure changes may not always be observable at the wellbore surface during fluid diversion and/or fracture network dilation. By way of nonlimiting example, fluid diversion because of placement of a secondary diverting agent may occur without an observable by 20 an increase in fluid pressure at the wellbore surface. [0040] In some embodiments, an element may be introduced into the wellbore after the wellbore pressure increases and begins to level off. In some embodiments, an element may be introduced into the wellbore during substantially steady-state wellbore pressure. By way of nonlimiting example, 25 Figure 5 illustrates two possible operations using methods of the present invention. In Scenario 1, propping agents are introduced in a periodic fashion; while in Scenario 2, the propping agents are introduced continuously and increased step-wise over time. At steady-state wellbore pressure, secondary diverting agent is added in twice followed by introduction of the primary 30 diverting agent. The primary diverting agent substantially blocks the flow of fluid through an access conduit causing wellbore pressure to increase. These steps are repeated with similar results. [0041] In some embodiments, monitoring the flow of one or more treatment fluids in at least a portion of the subterranean formation may be 35 accomplished, in part, by using a distributed temperature sensing (DTS) 11 WO 2013/028298 PCT/US2012/047787 technique. These techniques may involve a series of steps. Generally, a temperature sensing device (e.g., thernocouples, thermistors, or fiber optic cables) may be placed in a wellbore penetrating a portion of a subterranean formation, either permanently or retrievably, to record temperature data in the 5 formation and/or the wellbore. In certain applications, a fiber optic cable may be pre-installed in a casing string before the casing string is placed in the wellbore. In some applications, it may be desirable to use an additional apparatus (e.g., coiled tubing) or fluid to place the fiber optic cable in the wellbore. In some embodiments, one may establish baseline temperature profile 10 for all or part of the subterranean formation, and then monitor changes in temperature to determine the flow of fluids in various portions of the subterranean formation. Various cornputer software packages may be used to process the temperature data and/or create visualizations based on that data. Certain DTS techniques that may be suitable for use in the methods of the 15 present invention may include commercially-available DTS services such as those known under the tradenarnes STIMWATCH* (available from Halliburton Energy Services, Inc., Duncan, OK) or SENSA T (available from Schlumberger Technology Corporation, Sugar Land, TX). Certain examples of DTS techniques that may be suitable for use in the methods of the present invention also may 20 include those described in U.S. Patent Numbers 5,028,146; 6,557,630; 6,751,556; 7,055,604; and 7,086,484, the entire disclosures of which are incorporated herein by reference. One of ordinary skill in the art, with the benefit of this disclosure, should recognize whether it is desirable to monitor the flow of one or more treatment fluids in at least a portion of the subterranean 25 formation as well as techniques of doing so appropriate for a particular application of the present invention based on, inter alia, the characteristics of various portions of the subterranean formation, the types of treatment fluids present, equipment availability, and other relevant factors. [0042] The methods of the present invention may be used in any 30 subterranean formation capable of being fractured. Formations where the present methods rnay be most advantageous include, but are not limited to, formations with at least a portion of the formation characterized by very low permeability; very low formation pore throat size; high closure pressures; high brittleness index; and any combination thereof. 12 WO 2013/028298 PCT/US2012/047787 [0043] In some embodiments, at least a portion of a subterranean formation may have a permeability ranging from a lower limit of about 0.1 nano Darcy (nD), I nD, 10 nD, 25 nD, 50 nD, 100 nD, or 500 nD to an upper limit of about 10 mD, 1 mD, 500 microD, 100 microD, 10 microD, or 500 nD, and 5 wherein the permeability may range from any lower limit to any upper limit and encompass any subset therebetween. One method to determine the subterranean formation permeability includes The American Petroleum Institute Recommended Practice 40, "Recommended Practices for Core Analysis," Second Edition, February 1998, the entirety of which is incorporated herein by reference. 10 [0044] In some embodiments, at least a portion of a subterranean formation may have an average formation pore throat size ranging from a lower limit of about 0.005 microns, 0.01 microns, 0.05 microns, 0.1 microns, 0.25 microns, or 0.5 microns to an upper limit of about 2.0 microns, 1.5 microns, 1.0 microns, or 0.5 microns, and wherein the average formation pore throat size 15 may range from any lower limit to any upper limit and encompass any subset therebetween. One method to determine the pore throat size of a subterranean formation includes the AAPG Bulletin, March 2009, v. 93, no. 3, pages 329-340, the entirety of which is incorporated herein by reference. [0045] In some embodiments, at least a portion of a subterranean 20 formation may have a closure pressure greater than about 500 psi to an unlimited upper limit. While the closure pressure upper limit is believed to be unlimited, formations where the methods of the present invention may be applicable include formations with a closure pressure ranging from a lower limit of about 500 psi, 1000 psi, 1500 psi, or 2500 psi to an upper limit of about 25 20,000 psi, 15,000 psi, 10,000 psi, 8500 psi, or 5000 psi, and wherein the closure pressure may range from any lower limit to any upper limit and encompass any subset therebetween. One method to determine the subterranean formation closure pressure includes the method presented in the Society for Petroleum Engineers paper number 60321, the entirety of which is 30 incorporated herein by reference. [0046] In some embodiments, at least a portion of a subterranean formation may have a brittleness index ranging from a lower limit of about 5, 10, 20, 30, 40, or 50 to an upper limit of about 150, 125, 100, or 75, and wherein the brittleness index may range from any lower limit to any upper limit 35 and encompass any subset therebetween. Brittleness is a composite of Poisson's 13 WO 2013/028298 PCT/US2012/047787 ratio and Young's modulus. One method to determine the brittleness index of a subterranean formation includes the method presented in the Society for Petroleum Engineers paper number 132990, the entirety of which is incorporated herein by reference. 5 [0047] In certain embodiments, all or part of a welibore penetrating the subterranean formation may include casing pipes or strings placed in the wellbore (a "cased hole" or a "partially cased hole"), among other purposes, to facilitate production of fluids out of the formation and through the wellbore to the surface. In other embodiments, the wellbore may be an "open hole" that 10 has no casing. [0048] In some embodiments, the methods disclosed herein may be used in conjunction with zipper fracture techniques. Zipper fracture techniques use pressurized fracture networks in at least one wellbore to direct the fracture network of a second, nearby wellbore. Because the first fracture network is 15 pressurized and exerting a stress on the subterranean formation, the second pressure network may extend through the path of least resistance, i~e,, the portions of the subterranean formation under less stress. Continuing to hold open portions of the fracture network with propping agent may continue to provide stress on the subterranean formation even with a reduced fluid pressure 20 therein. Therefore, enhancing the uniform distribution of propping agents through a fracture network may enhance efficacy of a zipper fracture technique. In some embodiments, any of the diversion methods described herein may be implemented in at least one welibore to enhance the fracture network of at least one nearby wellbore. 25 [0049] Suitable diverting agents (primary or secondary) for use in the present invention may be any known diverting agent including, but not limited to, any known lost circulation material, bridging agent, fluid loss control agent, diverting agent, plugging agent, or the like suitable for use in a subterranean formation. Suitable diverting agents may comprise gels, particles, and/or fibers 30 that are natural or synthetic; degradable or nondegradable; and mixtures thereof. Nonlimiting examples of commercially available diverting agents include diverting agents in the BIOVERT* series degradablee diverting agents, available from Halliburton Energy Services, Inc.) including, but not limited to BIOVERT*NWB (a biomodal, degradable diverting agent, available from 35 Halliburton Energy Services, Inc.) as a primary diverting agent and BIOVERT*CF 14 WO 2013/028298 PCT/US2012/047787 (a degradable diverting agent, available from Halliburton Energy Services, Inc.) as a secondary diverting agent. [0050] Primary diverting agents for use in the present invention may comprise particulates. In some embodiments, particulates of a primary diverting 5 agent may have an average diameter ranging from a lower limit of about 0.5 microns, I micron, 10 microns, 100 microns, or 500 microns to an upper limit of about 1.0 mm, 5 mm, 1 mm, 500 microns, or 100 microns, and wherein the average diameter may range from any lower limit to any upper limit and encompass any subset therebetween. In some embodiments, particulates of a 10 primary diverting agent may have a multi-nodal diameter distribution including bimodal. [0051] Secondary diverting agents for use in the present invention may comprise articulates. In some embodiments, particulates of a secondary diverting agent may have an average diameter less than about 150 microns. 15 Suitable average diameters for particulates of a secondary diverting agent may range from a lower limit of about 100 nm, 250 nm, 500 nm, 1. micron, 10 microns, or 50 microns to an upper limit of about 150 microns, 100 microns, 50 microns, or 10 microns, and wherein the average diameter may range from any lower limit to any upper limit and encompass any subset therebetween. In some 20 embodiments, the secondary diverting agent may have an average diameter less than or equal to a proppant particulate of the propping agents. In some embodiments, the prirnary diverting agent may comprise particulates with a larger average diameter than particulates of a secondary diverting agent. [0052] Suitable examples of materials for a diverting agent include, but 25 are not limited to, sand, shale, ground marble, bauxite, ceramic materials, glass materials, metal pellets, high strength synthetic fibers, cellulose flakes, wood, resins, polymer materials (crosslinked or otherwise), polytetrafluoroethylene materials, nut shell pieces, cured resinous particulates comprising nut shell pieces, seed shell pieces, cured resinous particulates comprising seed shell 30 pieces, fruit pit pieces, cured resinous articulates comprising fruit pit pieces, composite particulates, and any combination thereof. Suitable composite particulates may comprise a binder and a filler rnaterial wherein suitable filler materials include silica, alumina, fumed carbon, carbon black, graphite, mica, titanium dioxide, meta-silicate, calcium silicate, kaolin, talc, zirconia, boron, fly 35 ash, hollow glass microspheres, solid glass, and any combination thereof. 15 WO 2013/028298 PCT/US2012/047787 [0053] In some embodiments, a diverting agent may be at least partially degradable. Nonlimiting examples of suitable degradable materials that may be used in the present invention include, but are not limited to, degradable polymers (crosslinked or otherwise), dehydrated compounds, and/or mixtures of 5 the two. Examples of suitable degradable solid particulates may be found in U.S. Patent Numbers 7,036,587; 6,896,058; 6,323,307; 5,216,050; 4,387,769; 3,912,692; and 2,703,316, the relevant disclosures of which are incorporated herein by reference. The terms "polymer" or "polymers" as used herein do not imply any particular degree of polymerization; for instance, oligomers are 10 encompassed within this definition. A polymer is considered to be "degradable" herein if it is capable of undergoing an irreversible degradation when used in subterranean applications, e.g., in a wellbore. The term "irreversible" as used herein means that the degradable material should degrade in situ (e.g., within a wellbore) but should not recrystallize or reconsolidate in situ after degradation 15 (e.g., in a welibore). [0054] Degradable materials may include, but not be limited to, dissolvable materials, materials that deform or melt upon heating such as thermoplastic materials, hydrolytically degradable materials, materials degradable by exposure to radiation, materials reactive to acidic fluids, or any 20 combination thereof. In some embodiments, degradable materials may be degraded by temperature, presence of moisture, oxygen, microorganisms, enzymes, pH, free radicals, and the like. In some embodiments, degradation may be initiated in a subsequent treatment fluid introduced into the subterranean formation at some time when diverting is no longer necessary. In 25 some embodiments, degradation may be initiated by a delayed--release acid, such as an acid-releasing degradable material or an encapsulated acid, and this may be included in the treatment fluid comprising the degradable material so as to reduce the pH of the treatment fluid at a desired time, for example, after introduction of the treatment fluid into the subterranean formation. 30 [0055] In choosing the appropriate degradable material, one should consider the degradation products that will result. Also, these degradation products should not adversely affect other operations or components. For example, a boric acid derivative may not be included as a degradable material in the well drill--in and servicing fluids of the present invention where such fluids 35 use guar as the viscosifier, because boric acid and guar are generally 16 WO 2013/028298 PCT/US2012/047787 incompatible. One of ordinary skill in the art, with the benefit of this disclosure, will be able to recognize when potential components of a treatment fluid of the present invention would be incompatible or would produce degradation products that would adversely affect other operations or components. 5 [0056] The degradability of a degradable polymer often depends, at least in part, on its backbone structure. For instance, the presence of hydrolyzable and/or oxidizable linkages in the backbone often yields a material that will degrade as described herein. The rates at which such polymers degrade are dependent on the type of repetitive unit, composition, sequence, length, 10 molecular geometry, molecular weight, morphology (e.g., crystallinity, size of spherulites, and orientation), hydrophilicity, hydrophobicity, surface area, and additives. Also, the environment to which the polymer is subjected may affect how it degrades, eg., temperature, presence of moisture, oxygen, microorganisms, enzymes, pH, and the like. 15 [0057] Suitable examples of degradable polymers for a solid particulate of the present invention that may be used include, but are not limited to, polysaccharides such as cellulose; chitin; chitosan; and proteins. Suitable examples of degradable polymers that may be used in accordance with the present invention include, but are not limited to, those described in the 20 publication of Advances in Polymer Science, Vol. 157 entitled "Degradable Aliphatic Polyesters," edited by A. C. Albertsson, pages 1-138. Specific examples include homopolymers, random, block, graft, and star- and hyper branched aliphatic polyesters. Such suitable polymers may be prepared by polycondensation reactions, ring-opening polymerizations, free radical 25 polymerizations, anionic polymerizations, carbocationic polymerizations, coordinative ring-opening polymerizations, as well as by any other suitable process. Examples of suitable degradable polymers that may be used in conjunction with the methods of this invention include, but are not limited to, aliphatic polyesters; poly(lactides); poly(glycolides); poly(E-caprolactones); 30 poly(hydroxy ester ethers); poly(hydroxybutyrates); poly(anhydrides); polycarbonates; poly(orthoesters); poly(arnino acids); poly(ethylene oxides); poly(phosphazenes); poly(ether esters), polyester aides, polyamides, and copolymers or blends of any of these degradable polymers, and derivatives of these degradable polymers. The term "copolymer" as used herein is not limited 35 to the combination of two polymers, but includes any combination of polymers, 17 WO 2013/028298 PCT/US2012/047787 e.g., terpolymers and the like. As referred to herein, the term "derivative" is defined herein to include any compound that is made from one of the listed compounds, for example, by replacing one atom in the base compound with another atom or group of atoms. Of these suitable polymers, aliphatic 5 polyesters such as poly(lactic acid), poly(anhydrides), poly(orthoesters), and poly(lactide)-co-poly(glycolide) copolymers are preferred. Poly(lactic acid) is especially preferred. Poly(orthoesters) also may be preferred. Other degradable polymers that are subject to hydrolytic degradation also may be suitable. One's choice may depend on the particular application and the conditions involved. 10 Other guidelines to consider include the degradation products that result, the time required for the requisite degree of degradation, and the desired result of the degradation (e.g., voids). [0058] Aliphatic polyesters degrade chemically, inter alia, by hydrolytic cleavage. Hydrolysis can be catalyzed by either acids or bases. Generally, 15 during the hydrolysis, carboxylic end groups may be formed during chain scission, which may enhance the rate of further hydrolysis. This mechanism is known in the art as autocatalysiss," and is thought to make polyester matrices more bulk-eroding. [0059] Suitable aliphatic polyesters have the general formula of 20 repeating units shown below: R Formula I where n is an integer between 75 and 10,000 and R is selected from the group consisting of hydrogen, alkyl, aryl, alkylaryl, acetyl, heteroatoms, and mixtures 25 thereof. In certain embodiments of the present invention wherein an aliphatic polyester is used, the aliphatic polyester may be poly(lactide). Poly(lactide) is synthesized either from lactic acid by a condensation reaction or, more commonly, by ring-opening polymerization of cyclic lactide monomer. Since both lactic acid and lactide can achieve the same repeating unit, the general 18 WO 2013/028298 PCT/US2012/047787 term poly(lactic acid) as used herein refers to writ of formula I without any limitation as to how the polymer was made (e.g., from lactides, lactic acid, or oligomers), and without reference to the degree of polymerization or level of plasticization. 5 [0060] The lactide monomer exists generally in three different forms: two stereoisomers (L- and D-lactide) and racemic D,L-lactide (meso-lactide). The oligomers of lactic acid and the oligomers of lactide are defined by the formula: HO m H Formula II 10 where m is an integer in the range of from greater than or equal to about 2 to less than or equal to about 75. In certain embodiments, m may be an integer in the range of from greater than or equal to about 2 to less than or equal to about 10. These limits may correspond to number average molecular weights below 15 about 5,400 and below about 720, respectively. The chirality of the lactide units provides a means to adjust, inter alia, degradation rates, as well as physical and mechanical properties. Poly(L-lactide), for instance, is a semicrystalline polymer with a relatively slow hydrolysis rate. This could be desirable in applications of the present invention in which a slower degradation of the degradable material is 20 desired. Poly(DL--lactide) may be a more amorphous polymer with a resultant faster hydrolysis rate. This may be suitable for other applications in which a more rapid degradation may be appropriate. The stereoisomers of lactic acid may be used individually, or may be combined in accordance with the present invention. Additionally, they may be copolymerized with, for example, glycolide 25 or other monomers like -caprolactone, 1,5-dioxepan-2-one, trimethylene carbonate, or other suitable monomers to obtain polymers with different properties or degradation times. Additionally, the lactic acid stereoisomers can be modified by blending high and low molecular weight polylactide or by blending polylactide with other polyesters. In embodiments wherein polylactide 30 is used as the degradable material, certain preferred embodiments employ a 19 WO 2013/028298 PCT/US2012/047787 mixture of the D and L stereoisomers, designed so as to provide a desired degradation time and/or rate. Examples of suitable sources of degradable material are commercially available 625ODM (poly(lactic acid), available from Cargill Dow) and 5639A-" (poly(lactic acid), available from Cargill Dow). 5 [0061] Aliphatic polyesters useful in the present invention may be prepared by substantially any of the conventionally known manufacturing methods such as those described in U.S. Patent Numbers 2,703,316; 3,912,692; 4,387,769; 5,216,050; and 6,323,307, the relevant disclosures of which are incorporated herein by reference. 10 [0062] Polyanhydrides are another type of degradable polymer that may be suitable for use in the present invention. Polyanhydride hydrolysis proceeds, inter a/ia, via free carboxylic acid chain-ends to yield carboxylic acids as final degradation products. Their erosion time can be varied over a broad range of changes in the polymer backbone. Examples of suitable polyanhydrides 15 include poly(adipic anhydride), poly(suberic anhydride), poly(sebacic anhydride), and poly(dodecanedioic anhydride). Other suitable examples include, but are not limited to, poly(maleic anhydride) and poly(benzoic anhydride). [0063] The physical properties of degradable polymers may depend on several factors including, but not limited to, the composition of the repeat units, 20 flexibility of the chain, presence of polar groups, molecular mass, degree of branching, crystallinity, and orientation. For example, short chain branches may reduce the degree of crystallinity of polymers while long chain branches rnay lower the melt viscosity and may impart, inter alia, extensional viscosity with tension-stiffening behavior. The properties of the material utilized further may 25 be tailored by blending, and copolymerizing it with another polymer, or by a change in the macromolecular architecture (e.g., hyper-branched polymers, star-shaped, or dendrimers, and the like). The properties of any such suitable degradable polymers (e.g., hydrophobicity, hydrophilicity, rate of degradation, and the like) can be tailored by introducing select functional groups along the 30 polymer chains. For example, poly(phenyllactide) will degrade at about one-fifth of the rate of racemic poly(lactide) at a pH of 7.4 at 55 IC. One of ordinary skill in the art, with the benefit of this disclosure, will be able to determine the appropriate functional groups to introduce to the polymer chains to achieve the desired physical properties of the degradable polymers. 20 WO 2013/028298 PCT/US2012/047787 [0064] Suitable dehydrated compounds for use as solid particulates in the present invention may degrade over time as they are rehydrated. For example, a particulate solid anhydrous borate material that degrades over time may be suitable for use in the present invention. Specific examples of 5 particulate solid anhydrous borate materials that may be used include, but are not limited to, anhydrous sodium tetraborate (also known as anhydrous borax) and anhydrous boric acid. [0065] Whichever degradable material is used in the present invention, the degradable material may have any shape, including, but not limited to, 10 particles having the physical shape of platelets, shavings, flakes, ribbons, rods, strips, spheroids, toroids, pellets, tablets, or any other physical shape. In certain embodiments of the present invention, the degradable material used may comprise a mixture of fibers and spherical particles. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the specific degradable 15 material that may be used in accordance with the present invention, and the preferred size and shape for a given application. [0066] In choosing the appropriate degradable material, one should consider the degradation products that will result, and choose a degradable material that will not yield degradation products that would adversely affect 20 other operations or components utilized in that particular application. The choice of degradable material also may depend, at least in part, on the conditions of the well (e.g., wellbore temperature). For instance, lactides have been found to be suitable for lower temperature wells, including those within the range of 60 IF to 150 0 F, and polylactides have been found to be suitable for wellbore 25 temperatures above this range. [0067] In certain embodiments, the degradation of the degradable material could result in a final degradation product having the potential to affect the pH of the self-degrading cement compositions utilized in the methods of the present invention. For example, in certain embodiments wherein the degradable 30 material is poly(lactic acid), the degradation of the poly(lactic acid) to produce lactic acid may alter the pH of the self-degrading cement composition. In certain embodiments, a buffer compound may be included within the self-degrading cement compositions utilized in the methods of the present invention in an amount sufficient to neutralize the final degradation product. Examples of 35 suitable buffer compounds include, but are not limited to, calcium carbonate, 21 WO 2013/028298 PCT/US2012/047787 magnesium oxide, ammonium acetate, and the like. One of ordinary skill in the art, with the benefit of this disclosure, will be able to identify the proper type and concentration of a buffer compound to include in the self-degrading cement composition for a particular application. An example of a suitable buffer 5 compound comprises commercially available BA-20M (ammonium acetate, available from Halliburton Energy Services, Inc.). [0068] In some embodiments, a diverting agent may be a gel. In some embodiments, the gel may be a crosslinked gel. Examples of gel diverting agents rnay include, but not be limited to, fluids with high concentration of gels 10 such as xanthan. Examples of crosslinked gels that can be used as the diverting agent include, but are not limited to, high concentration gels such as DELTA FRACTM fluids (high viscosity borate gel, available from Halliburton Energy Services, Inc.), K-MAXT" fluids (crosslinkable hydroxyethyl cellulose, available from Halliburton Energy Services, Inc.), and K-MAX-PLUSA fluids (crosslinkable 15 hydroxyethyl cellulose, available from Halliburton Energy Services, Inc.), Gels may also be used by mixing the crosslinked gels with delayed chemical breakers, encapsulated chemical breakers, which will later reduce the viscosity, or with a material such as PLA (poly-lactic acid) beads, which although being a solid material, with time decomposes into acid, which will liquefy the K-MAXTM fluids 20 or other crosslinked gels. [0069] The gel diverting agents suitable for use in the present invention may comprise any substance (e.g., a polymeric material) capable of increasing the viscosity of the treatment fluid. In certain embodiments, the gelling agent may comprise one or more polymers that have at least two molecules that are 25 capable of forming a crosslink in a crosslinking reaction in the presence of a crosslinking agent, and/or polymers that have at least two molecules that are so crosslinked (i.e., a crosslinked gelling agent). The gel diverting agents may be naturally-occurring gel diverting agents, synthetic gel diverting agents, or a combination thereof. The gel diverting agents also may be cationic, anionic, 30 amphoteric, or a combination thereof. Suitable gel diverting agents include, but are not limited to, polysaccharides, biopolymers, and/or derivatives thereof that contain one or more of these monosaccharide units: galactose, rnannose, glucoside, glucose, xylose, arabinose, fructose, glucuronic acid, or pyranosyl sulfate. Examples of suitable polysaccharides include, but are not limited to, 35 guar gums (e.g., hydroxyethyl guar, hydroxypropyl guar, carboxymethyl guar, 22 WO 2013/028298 PCT/US2012/047787 carboxymethylhyd roxyethyl guar, and carboxymethylhydroxypropyl guar ("CMHPG")), cellulose derivatives (e.g., hydroxyethyl cellulose, carboxyethylcellulose, carboxymethylcellulose, and carboxymethylhydroxyethylcellulose), xanthan, scleroglucan, diutan, and 5 combinations thereof. In certain embodiments, the gelling agents comprise an organic carboxylated polymer, such as CMHPG. [0070] Suitable synthetic polymers for use as gel diverting agents include, but are not limited to, 2,2'-azobis(2,4-dimethyl valeronitrile), 2,2' azobis(2,4-dimethyl-4-methoxy valeronitrile), polymers and copolymers of 10 acrylamide ethyltrimethyl ammonium chloride, acrylamide, acrylamido-and methacrylamido-alkyl trialkyl ammonium salts, acrylamidomethylpropane sulfonic acid, acrylamidopropyl trimethyl ammonium chloride, acrylic acid, dirnethylaminoethyl methacrylamide, dimethylaminoethyl methacrylate, dimethylaminopropyl methacrylamide, dimethylaminopropylmethacrylamide, 15 dimethyldiallylammonium chloride, dimethylethyl acrylate, fumaramide, methacrylamide, methacrylamidopropyl trimethyl ammonium chloride, methacrylamidopropyldimethyl-n-dodecylammonium chloride, methacrylamidopropyldimethyl-n-octylammonium chloride, methacrylamidopropyltrimethylammonium chloride, methacryloylalkyl trialkyl 20 ammonium salts, methacryloylethyl trimethyl ammonium chloride, methacrylylamidopropyldimethylcetylammonium chloride, N-(3-sulfopropyl)-N methacrylamidopropyl-N,N-dimethyl ammonium betaine, NN dimethylacrylam ide, N-methylacrylamide, nonylphenoxypoly(ethyleneoxy)ethylmethacrylate, partially hydrolyzed 25 polyacrylamide, poly 2-amino-2-methyl propane sulfonic acid, polyvinyl alcohol, sodium 2-acrylamido-2-methylpropane sulfonate, quaternized dimethylaminoethylacrylate, quaternized dimethylaminoethylmethacrylate, and derivatives and combinations thereof. In certain embodiments, the gelling agent comprises an acrylamide/2-(methacryloyloxy)ethyltrimethylammonium methyl 30 sulfate copolymer. In certain embodiments, the gelling agent may comprise an acrylarnide/2-(methacryloyloxy)ethyltrirnethylammonium chloride copolymer. In certain embodiments, the gelling agent may comprise a derivatized cellulose that comprises cellulose grafted with an allyl or a vinyl monomer, such as those disclosed in U.S, Patent Numbers 4,982,793; 5,067,565; and 5,122,549, the 35 entire disclosures of which are incorporated herein by reference. 23 WO 2013/028298 PCT/US2012/047787 [0071] Additionally, polymers and copolymers that comprise one or more functional groups (e.g., hydroxyl, cis-hydroxyl, carboxylic acids, derivatives of carboxylic acids, sulfate, sulfonate, phosphate, phosphonate, amino, or amide groups) may be used as gel diverting agents. 5 [0072] In those embodiments of the present invention where it is desirable to crosslink the gel diverting agents in situ, the treatment fluid comprising the gel diverting agents and/or a subsequent treatment fluid may comprise one or more crosslinking agents. The crosslinking agents may comprise a borate ion, a metal ion, or similar component that is capable of 10 crosslinking at least two molecules of the gelling agent. Examples of suitable crosslinking agents include, but are not limited to, borate ions, magnesium ions, zirconium IV ions, titanium IV ions, aluminum ions, antimony ions, chromium ions, iron ions, copper ions, magnesium ions, and zinc ions. These ions may be provided by providing any compound that is capable of producing one or more of 15 these ions. Examples of such compounds include, but are not limited to, ferric chloride, boric acid, disodium octaborate tetrahydrate, sodium diborate, pentaborates, ulexite, colemanite, magnesium oxide, zirconium lactate, zirconium triethanol amine, zirconium lactate triethanolamine, zirconium carbonate, zirconium acetylacetonate, zirconium malate, zirconium citrate, 20 zirconium diisopropylamine lactate, zirconium glycolate, zirconium triethanol amine glycolate, zirconium lactate glycolate, titanium lactate, titanium rnalate, titanium citrate, titanium ammonium lactate, titanium triethanolamine, and titanium acetylacetonate, aluminum lactate, aluminum citrate, antimony compounds, chromium compounds, iron compounds, copper compounds, zinc 25 compounds, and combinations thereof. In certain embodiments of the present invention, the crosslinking agent may be formulated to remain inactive until it is "activated" by, among other things, certain conditions in the fluid (e.g., pH, temperature, etc.) and/or interaction with some other substance. In some embodiments, the activation of the crosslinking agent may be delayed by 30 encapsulation with a coating (e.g., a porous coating through which the crosslinking agent may diffuse slowly, or a degradable coating that degrades downhole) that delays the release of the crosslinking agent until a desired time or place, The choice of a particular crosslinking agent may be governed by several considerations that should be recognized by one skilled in the art, 35 including, but not limited to, the following: the type of gelling agent included, 24 WO 2013/028298 PCT/US2012/047787 the molecular weight of the gel diverting agents, the conditions in the subterranean formation being treated, the safety handling requirements, the pH of the treatment fluid, temperature, and/or the desired delay for the crosslinking agent to crosslink the gel diverting agents. 5 [0073] Examples of suitable degradable gel diverting agents may be "stimuli-degradable" and can be found in U.S. Patent Number 7,306,040, the relevant disclosure of which is incorporated herein by reference. Stimuli that may lead to the degradation of stimuli-degradable gel diverting agents include any change in the condition or properties of the gel including, but not limited to, 10 a change in pH (e.g., caused by the suffering action of the rock or the decomposition of materials that release chemicals such as acids) or a change in the temperature (e.g., caused by the contact of the fluid with the rock formation). [0074] To form stimuli-degradable gel diverting agents, degradable 15 crosslinkers may be used to crosslink gelling agents comprising "ethylenically unsaturated monomers." Suitable gelling agents for stimuli-degradable gel diverting agents include, but are not limited to, ionizable monomers (such as 1 N,N-diethylaminoethylmethacrylate); diallyldimethylammonium chloride; 2 acrylamido-2-methyl propane sulfonate; acrylic acid; allylic monomers (such as 20 di-allyl phthalate; di-allyl maleate; allyl diglycol carbonate; and the like); vinyl formate; vinyl acetate; vinyl propionate; vinyl butyrate; crotonic acid; itaconic acid acrylamide; methacrylamide; methacrylonitrile; acrolein; methyl vinyl ether; ethyl vinyl ether; vinyl ketone; ethyl vinyl ketone; allyl acetate; allyl propionate; diethyl maleate; any derivative thereof; and any combination 25 thereof. [0075] In some embodiments, the degradable crosslinker for use in stimuli-degradable gel diverting agents may contain a degradable group(s) including, but not limited to, esters, phosphate esters, amides, acetals, ketals, orthoesters, carbonates, anhydrides, silyl ethers, alkene oxides, ethers, mines, 30 ether esters, ester amides, ester urethanes, carbonate urethanes, amino acids, any derivative thereof, or any combination thereof. The choice of the degradable group may be determined by pH and temperature, the details of which are available in known literature sources. The unsaturated terminal groups may include substituted or unsubstituted ethylenically unsaturated 35 groups, vinyl groups, allyl groups, acryl groups, or acryloyl groups, which are 25 WO 2013/028298 PCT/US2012/047787 capable of undergoing polymerization with the above-mentioned gelling agents to form crosslinked gel diverting agents. Suitable degradable crosslinkers for stirnuli-degradable gel diverting agents include, but are not limited to, unsaturated esters such as diacrylates, dimethacrylates, and dibutyl acrylates; 5 acrylamides; ethers such as divinyl ethers; and combinations thereof. Specific examples include, but are not limited to, polyethylene glycol) diacrylate; polyethyleneglycol dimethacrylate; polyethyleneglycol divinyl ether; polyethylene glycol divinylamide; polypropylene glycol diglycidyl ether; polypropylene glycol diacrylate; poly(propylene glycol dimethacrylate); 10 bisacrylamide; and combinations thereof. In one embodiment, a stimuli degradable crosslinking agent comprises one or more degradable crosslink and two vinyl groups. Some embodiments of these crosslinking agents are sensitive to changes in pH, such as ortho ester-based embodiments, acetal-based embodiments, ketal-based embodiments, and silicon-based embodiments. 15 Generally speaking, at room temperature, the ortho ester-based embodiments should be stable at pHs of above 10, and should degrade at a pH below about 9; the acetal-based embodiments should be stable at pHs above about 8 and should degrade at pH below about 6; the ketal-based embodiments should be stable at pHs of about 7 and should degrade at a pH below 7; and the silicon 20 based embodiments should be stable at pHs above about 7 and should degrade faster in acidic media. Thus, under moderately acidic conditions (pH of around 3), the relative stability of these groups should decrease in the following order: amides>ketals>orthoester. At higher wellbore temperatures, the more stable crosslinking groups contain amides or ethers and would be preferred over other 25 choices including esters, acetals, and ketals. [0076] The gel diverting agents may be present in the treatment fluids useful in the methods of the present invention in an amount sufficient to provide the desired viscosity. In some embodiments, the gel diverting agents may be present in an amount in the range of from a lower limit of about 0.1%, 0.15%, 30 0.25%, 0.5%, 1%, 5%, or 10% by weight of the treatment fluid to an upper limit of about 40%, 30%, 25%, or 10% by weight of the treatment fluid, and wherein the amount may range from any lower limit to any upper limit and encompass any subset therebetween. [0077] When included, suitable crosslinking agents may be present in 35 the treatment fluids useful in the methods of the present invention in an amount 26 WO 2013/028298 PCT/US2012/047787 sufficient to provide the desired degree of crosslinking between molecules of the gel diverting agents. In certain embodiments, the crosslinking agent may be present in the first treatment fluids and/or second treatment fluids of the present invention in an amount in the range of from about 0.005% to about 1% 5 by weight of the treatment fluid. In certain embodiments, the crosslinking agent may be present in the treatment fluids of the present invention in an amount in the range of from about 0.05% to about 1% by weight of the first treatment fluid and/or the second treatment fluid. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of crosslinking 10 agent to include in a treatment fluid of the present invention based on, arong other things, the temperature conditions of a particular application, the type of gel diverting agents used, the molecular weight of the gel diverting agents, the desired degree of viscosification, and/or the pH of the treatment fluid. [0078] It should be rioted that any derivative, any mixture, and any 15 combination of the diverting agents described herein may be used as primary diverting agents or secondary diverting agents. Further, a primary diverting agent or a secondary diverting agent may be a hybrid of two or more diverting agents described herein. [0079] In some embodiments, treatment fluids comprising gel diverting 20 agents may include internal gel breakers such as enzyme, oxidizing, acid buffer, or delayed gel breakers. The gel breakers may cause the gel diverting agents of the present invention to revert to thin fluids that can be produced back to the surface, for example, after they have diverted fluid within a fracture network. In some embodiments, the gel breaker may be formulated to remain inactive until 25 it is "activated" by, among other things, certain conditions in the fluid (e.g., pH, temperature, etc.) and/or interaction with some other substance. In some embodiments, the gel breaker may be delayed by encapsulation with a coating (e.g., porous coatings through which the breaker may diffuse slowly, or a degradable coating that degrades downhole) that delays the release of the gel 30 breaker. In other embodiments the gel breaker may be a degradable material (e.g., polylactic acid or polygylcolic acid) that releases an acid or alcohol in the present of an aqueous liquid. In certain embodiments, the gel breaker used may be present in a treatment fluid in an amount in the range of from about 0.0001% to about 200% by weight of the gelling agent. One of ordinary skill in 35 the art, with the benefit of this disclosure, should recognize the type and amount 27 WO 2013/028298 PCT/US2012/047787 of a gel breaker to include in certain treatment fluids of the present invention based on, among other factors, the desired amount of delay time before the gel breaks, the type of gel diverting agents used, the temperature conditions of a particular application, the desired rate and degree of viscosity reduction, and/or 5 the pH of the treatment fluid. [0080] Degradable particulates for use in the present invention may have an average diameter about the diameter of the propping agents including, but not limited to, about 2 mesh to about 400 mesh on the U.S. Sieve Series. However, in certain circumstances, other mean particulate sizes may be desired 10 and will be entirely suitable for practice of the present invention. [0081] Degradable particles may comprise any materials suitable for use in a subterranean formation provided at least a portion of the degradable particulate is degradable. Suitable compositions include those disclosed herein for use in diverting agents including any derivative, any mixture, and any 15 combination thereof. A nonlimiting example of a commercially available degradable particulate includes degradable particulates in the BIOVOID* series (degradable particles, available from Halliburton Energy Services, Inc.). Degradable particles may be self-degradable, stimuli-degradable, or any combination thereof. In some embodiments, a treatment fluid may be 20 introduced into the wellbore with an additive designed to initiate, accelerate, slow, or delay degradation of the degradable particles. In some embodiments, such an additive may be introduced simultaneously with the degradable particulates. [0082] In certain embodiments, propping agents for use in the present 25 invention may comprise a plurality of proppant particulates. Proppant particulates suitable for use in the present invention may comprise any material suitable for use in subterranean operations. Suitable materials for these proppant particulates include, but are not limited to, sand, bauxite, ceramic materials, glass materials, polymer materials, polytetrafluoroethylene materials, 30 nut shell pieces, cured resinous particulates comprising nut shell pieces, seed shell pieces, cured resinous particulates comprising seed shell pieces, fruit pit pieces, cured resinous particulates comprising fruit pit pieces, wood, composite particulates, and combinations thereof. Suitable composite particulates may comprise a binder and a filler material wherein suitable filler materials include 35 silica, alumina, fumed carbon, carbon black, graphite, mica, titanium dioxide, 28 WO 2013/028298 PCT/US2012/047787 meta-silicate, calcium silicate, kaolin, talc, zirconia, boron, fly ash, hollow glass microspheres, solid glass, and combinations thereof. The mean particulate size generally may range frorn about 2 mesh to about 400 mesh on the U.S. Sieve Series; however, in certain circumstances, other mean particulate sizes may be 5 desired and will be entirely suitable for practice of the present invention. In particular embodiments, preferred mean particulates size distribution ranges are one or more of 6/12, 8/16, 12/20, 16/30, 20/40, 30/50, 40/60, 40/70, or 50/70 mesh. A proppant particle may be any known shape of material, including substantially spherical materials, fibrous materials, polygonal materials (such as 10 cubic materialss, and combinations thereof. Moreover, fibrous materials, that may or may not be used to bear the pressure of a closed fracture, may be included in certain embodiments of the present invention. In certain embodiments, the proppant particulates may be present in a treatment fluid for use in the present invention in an amount in the range of from about 0.1 pounds 15 per gallon ("ppg") to about 30 ppg by volume of the treatment fluid. [0083] In some embodiments, a primary diverting agent, a secondary diverting agent, a degradable particulate, a proppant particulate, or any combination thereof may be coated with a consolidating agent. As used herein, the term "coating," and the like, does not imply any particular degree of coating 20 on the particulate. In particular, the terms "coat" or "coating" do not imply 100% coverage by the coating on the particulate. In some embodiments, a primary diverting agent, a secondary diverting agent, a degradable particulate, a proppant particulate, or any combination thereof may be coated with a consolidating agent prior to introduction into a wellbore, after introduction into a 25 wellbore, simultaneous to introduction into a wellbore, or any combination thereof. In some embodiments, a coating, including degree of coating, may be used to control the rate of degradation of a primary diverting agent, a secondary diverting agent, a degradable particulate, a proppant particulate, or any combination thereof. 30 [0084] Consolidating agents suitable for use in the methods of the present invention generally comprise any compound that is capable of minimizing particulate migration. Nonlimiting examples of consolidating agents include SANDWEDGE* (an adhesive substance, available from Halliburton Energy Services, Inc.) and EXPEDITE* (a two-component resin system, available from 35 Halliburton Energy Services, Inc.). In some embodiments, the consolidating 29 WO 2013/028298 PCT/US2012/047787 agent may comprise a consolidating agent selected from the group consisting of: non-aqueous tackifying agents; aqueous tackifying agents; resins; silyl-modified polyamide compounds; crosslinkable aqueous polymer compositions; and consolidating agent emulsions. Mixtures, combinations, and/or derivatives of 5 these also may be suitable. The type and amount of consolidating agent included in a particular method of the present invention may depend upon, among other factors, the composition and/or temperature of the subterranean formation, the chemical composition of formation fluids, the flow rate of fluids present in the formation, the effective porosity and/or permeability of the 10 subterranean formation, pore throat size and distribution, and the like. Furthermore, the concentration of the consolidating agent can be varied, inter alia, to either enhance bridging to provide for a more rapid coating of the consolidating agent or to minimize bridging to allow deeper penetration into the subterranean formation. It is within the ability of one skilled in the art, with the 15 benefit of this disclosure, to determine the type and amount of consolidating agent to include in the methods of the present invention to achieve the desired results. [0085] In some embodiments, the consolidating agent may comprise a consolidating agent emulsion that comprises an aqueous fluid, an emulsifying 20 agent, and a consolidating agent. The consolidating agent in suitable emulsions may be either a non-aqueous tackifying agent or a resin. These consolidating agent emulsions have an aqueous external phase and organic-based internal phase. The term "emulsion" and any derivatives thereof as used herein refers to a combination of two or more immiscible phases and includes, but is not limited 25 to, dispersions and suspensions. [0086] Suitable consolidating agent emulsions comprise an aqueous external phase comprising an aqueous fluid. Suitable aqueous fluids that may be used in the consolidating agent emulsions of the present invention include freshwater, salt water, brine, seawater, or any other aqueous fluid that, 30 preferably, does not adversely react with the other components used in accordance with this invention or with the subterranean formation. One should note, however, that if long-terrn stability of the emulsion is desired, a more suitable aqueous fluid may be one that is substantially free of salts. It is within the ability of one skilled in the art, with the benefit of this disclosure, to 35 determine if and how much salt may be tolerated in the consolidating agent 30 WO 2013/028298 PCT/US2012/047787 emulsions of the present invention before it becomes problematic for the stability of the emulsion. The aqueous fluid may be present in the consolidating agent emulsions in an amount in the range of about 20% to 99.9% by weight of the consolidating agent emulsion composition. In some embodiments, the 5 aqueous fluid may be present in the consolidating agent emulsions in an amount in the range of about 60% to 99,9% by weight of the consolidating agent emulsion composition. In some embodiments, the aqueous fluid may be present in the consolidating agent emulsions in an amount in the range of about 95% to 99.9% by weight of the consolidating agent emulsion composition. 10 [0087] The consolidating agent in the emulsion may be either a non aqueous tackifying agent or a resin. The consolidating agents may be present in a consolidating agent emulsion in an amount in the range of about 0.1% to about 80% by weight of the consolidating agent emulsion composition. In some embodiments, the consolidating agent may be present in a consolidating agent 15 emulsion in an amount in the range of about 0.1% to about 40% by weight of the composition. In some embodiments, the consolidating agent may be present in a consolidating agent emulsion in an amount in the range of about 0.1% to about 5% by weight of the composition. [0088] As previously stated, the consolidating agent emulsions 20 comprise an emulsifying agent. Exarnples of suitable emulsifying agents may include surfactants, proteins, hydrolyzed proteins, lipids, glycolipids, and nanosized particulates, including, but not limited to, fumed silica. Combinations of these may be suitable as well. [0089] In some embodiments of the present invention, the 25 consolidating agent may comprise a non-aqueous tackifying agent. A particularly preferred group of non-aqueous tackifying agents comprises polyamides that are liquids or in solution at the temperature of the subterranean formation such that they are, by themselves, non-hardening when introduced into the subterranean formation. A particularly preferred product is a 30 condensation reaction product comprised of a commercially available polyacid and a polyamine. Such commercial products include compounds such as combinations of dibasic acids containing some trimer and higher oligomers and also small amounts of monomer acids that are reacted with polyamines. Other polyacids include trimer acids, synthetic acids produced from fatty acids, maleic 31 WO 2013/028298 PCT/US2012/047787 anhydride, acrylic acid, and the like. Combinations of these may be suitable as well. [0090] Additional compounds which rnay be used as non-aqueous tackifying agents include liquids and solutions of, for example, polyesters, 5 polycarbonates, silyl-modified polyamide compounds, polycarbamates, urethanes, natural resins such as shellac, and the like. Combinations of these may be suitable as well. [0091] Other suitable non-aqueous tackifying agents are described in U.S. Patent Numbers 5,353,048 and 5,333,000, and U.S. Patent Publication 10 Numbers 2007/0131425 and 2007/0131422, the relevant disclosures of which are herein incorporated by reference. [0092] Non-aqueous tackifying agents suitable for use in the present invention may either be used such that they forrn a non-hardening coating on a surface or they may be combined with a multifunctional material capable of 15 reacting with the non-aqueous tackifying agent to form a hardened coating. A "hardened coating" as used herein means that the reaction of the tackifying compound with the multifunctional material should result in a substantially non flowable reaction product that exhibits a higher compressive strength in a consolidated agglomerate than the tackifying compound alone with the 20 particulates. In this instance, the non-aqueous tackifying agent may function similarly to a hardenable resin. [0093] Multifunctional materials suitable for use in the present invention include, but are not limited to, aldehydes; dialdehydes such as glutaraldehyde; hemiacetals or aldehyde releasing compounds; diacid halides; dihalides such as 25 dichlorides and dibromides; polyacid anhydrides; epoxides; furfuraldehyde; aldehyde condensates; and silyl-modified polyamide compounds; and the like; and combinations thereof. Suitable silyl-modified polyamide compounds that may be used in the present invention are those that are substantially self hardening compositions capable of at least partially adhering to a surface or to a 30 particulate in the unhardened state, and that are further capable of self hardening themselves to a substantially non-tacky state to which individual particulates such as formation fines will not adhere to, for example, in formation or proppant pack pore throats. Such silyl-modified polyamides may be based, for example, on the reaction product of a silating compound with a polyamide or 35 a combination of polyamides. The polyamide or combination of polyamides may 32 WO 2013/028298 PCT/US2012/047787 be one or more polyamide intermediate compounds obtained, for example, from the reaction of a polyacid (e.g., diacid or higher) with a polyamine (e.g., diamine or higher) to form a polyamide polymer with the elimination of water. [0094] In some embodiments of the present invention, the 5 multifunctional material may be mixed with the tackifying compound in an amount of about 0.01% to about 50% by weight of the tackifying compound to effect formation of the reaction product. In other embodiments, the multifunctional material is present in an amount of about 0.5% to about 1% by weight of the tackifying compound. Suitable multifunctional materials are 10 described in U.S. Patent Number 5,839,510, the entire disclosure of which is herein incorporated by reference. [0095] Aqueous tackifying agents suitable for use in the present invention are usually not generally significantly tacky when placed onto a particulate, but are capable of being "activated" (e.g., destabilized, coalesced 15 and/or reacted) to transform the compound into a sticky, tackifying compound at a desirable time. Such activation may occur before, during, or after the aqueous tackifier agent is placed in the subterranean formation. In some embodiments, a pretreatment may be first contacted with the surface of a particulate to prepare it to be coated with an aqueous tackifier agent. Suitable aqueous 20 tackifying agents are generally charged polymers that comprise compounds that, when in an aqueous solvent or solution, will forrn a non-hardening coating (by itself or with an activator) and, when placed on a particulate, will increase the continuous critical resuspension velocity of the particulate when contacted by a stream of water. The aqueous tackifier agent may enhance the grain-to-grain 25 contact between the individual particulates within the formation (be they diverting agents, proppant particulates, formation fines, or other particulates), helping bring about the consolidation of the particulates into a cohesive, flexible, and permeable mass. [0096] Suitable aqueous tackifying agents include any polymer that can 30 bind, coagulate, or flocculate a particulate. Also, polyrers that function as pressure-sensitive adhesives may be suitable. Examples of aqueous tackifying agents suitable for use in the present invention include, but are not limited to: acrylic acid polymers; acrylic acid ester polymers; acrylic acid derivative polymers; acrylic acid homopolymers; acrylic acid ester homopolymers (such as 35 poly(methyl acrylate), poly(butyl acrylate), and poly(2-ethylhexyl acrylate)); 33 WO 2013/028298 PCT/US2012/047787 acrylic acid ester co-polymers; methacrylic acid derivative polymers; methacrylic acid homopolymers; methacrylic acid ester homopolymers (such as poly(methyl methacrylate), poly(butyl methacrylate), and poly(2-ethylhexyl rnethacrylate)); acrylamido-methyl-propane sulfonate polymers; acrylamido--methyl -propane 5 sulfonate derivative polymers; acrylamido--methyl-propane sulfonate co polymers; and acrylic acid/acrylamido--methyl-propane sulfonate co-polymers; derivatives thereof, and combinations thereof. Methods of determining suitable aqueous tackifying agents and additional disclosure on aqueous tackifying agents can be found in U.S. Patent Publication Numbers 2005/0277554 and 10 2005/0274517, the entire disclosures of which are hereby incorporated by reference. [0097] Some suitable tackifying agents are described in U.S. Patent Number 5,249,627, the entire disclosure of which is incorporated herein by reference, which discloses aqueous tackifying agents that comprise at least one 15 member selected from the group consisting of benzyl coco di--(hydroxyethyl) quaternary amine, p-T-amyl-phenol condensed with formaldehyde, and a copolymer comprising from about 80% to about 100% Cl-30 alkylmethacrylate monomers and from about 0% to about 20% hydrophilic monomers. In some embodiments, the aqueous tackifying agent may comprise a copolymer that 20 comprises from about 90% to about 99.5% 2-ethylhexylacrylate and from about 0.5% to about 10% acrylic acid. Suitable hydrophillic monomers may be any monorner that will provide polar oxygen-containing or nitrogen-containing groups. Suitable hydrophillic monomers include dialkyl amino alkyl (meth)acrylates and their quaternary addition and acid salts, acrylamide, N- 25 (dialkyl amino alkyl) acrylamide, methacrylamides and their quaternary addition and acid salts, hydroxy alkyl (meth)acrylates, unsaturated carboxylic acids such as methacrylic acid or acrylic acid, hydroxyethyl acrylate, acrylamide, and the like. Combinations of these may be suitable as well. These copolymers can be made by any suitable emulsion polymerization technique. Methods of producing 30 these copolymers are disclosed, for example, in U.S. Patent Number 4,670,501, the entire disclosure of which is incorporated herein by reference. [0098] In sorne embodiments of the present invention, the consolidating agent may comprise a resin. The term "resin" as used herein refers to any of numerous physically similar polymerized synthetics or chemically 35 modified natural resins including thermoplastic materials and thermosetting 34 WO 2013/028298 PCT/US2012/047787 materials. Resins that may be suitable for use in the present invention may include substantially all resins known and used in the art. [0099] One type of resin suitable for use in the methods of the present invention is a two-component epoxy-based resin comprising a liquid hardenable 5 resin component and a liquid hardening agent component. The liquid hardenable resin component comprises a hardenable resin and an optional solvent. The solvent may be added to the resin to reduce its viscosity for ease of handling, mixing and transferring. It is within the ability of one skilled in the art, with the benefit of this disclosure, to determine if and how much solvent 10 may be needed to achieve a viscosity suitable to the subterranean conditions. Factors that may affect this decision include geographic location of the well, the surrounding weather conditions, and the desired long-term stability of the consolidating agent. An alternate way to reduce the viscosity of the hardenable resin is to heat it. The second component is the liquid hardening agent 15 component, which comprises a hardening agent, an optional silane coupling agent, a surfactant, an optional hydrolyzable ester for, among other things, breaking gelled fracturing fluid films on particulates, and an optional liquid carrier fluid for, among other things, reducing the viscosity of the hardening agent component. 20 [0100] Examples of hardenable resins that can be used in the liquid hardenable resin component include, but are not limited to, organic resins such as bisphenol A diglycidyl ether resins, butoxymethyl butyl glycidyl ether resins, bisphenol A-epichlorohydrin resins, bisphenol F resins, polyepoxide resins, novolak resins, polyester resins, phenol-aldehyde resins, urea-aldehyde resins, 25 furan resins, urethane resins, glycidyl ether resins, other epoxide resins, and combinations thereof. In some embodiments, the hardenable resin may comprise a urethane resin. Examples of suitable urethane resins may comprise a polyisocyanate component and a polyhydroxy component. Examples of suitable hardenable resins, including urethane resins, that may be suitable for 30 use in the methods of the present invention include those described in U.S. Patent Numbers 4,585,064; 6,582,819; 6,677,426; and 7,153,575, the entire disclosures of which are herein incorporated by reference. [0101] The hardenable resin may be included in the liquid hardenable resin component in an amount in the range of about 5% to about 100% by 35 weight of the liquid hardenable resin component. It is within the ability of one 35 WO 2013/028298 PCT/US2012/047787 skilled in the art, with the benefit of this disclosure, to determine how much of the liquid hardenable resin component may be needed to achieve the desired results. Factors that may affect this decision include which type of liquid hardenable resin component and liquid hardening agent component are used. 5 [0102] Any solvent that is compatible with the hardenable resin and achieves the desired viscosity effect may be suitable for use in the liquid hardenable resin component. Suitable solvents may include butyl lactate, dipropylene glycol methyl ether, dipropylene glycol dimethyl ether, dimethyl formamide, diethyleneglycol methyl ether, ethyleneglycol butyl ether, 10 diethyleneglycol butyl ether, propylene carbonate, methanol, butyl alcohol, d'limonene, fatty acid methyl esters, and butylglycidyl ether, and combinations thereof. Other preferred solvents may include aqueous dissolvable solvents such as methanol, isopropanol, butanol, and glycol ether solvents, and combinations thereof. Suitable glycol ether solvents include, but are not limited to, diethylene 15 glycol methyl ether, dipropylene glycol methyl ether, 2-butoxy ethanol, ethers of a C2 to C6 dihydric alkanoi containing at least one Cl to C6 alkyl group, mono ethers of dihydric alkanols, methoxypropanol, butoxyethanol, and hexoxyethanol, and isomers thereof. Selection of an appropriate solvent is dependent on the resin composition chosen and is within the ability of one skilled 20 in the art, with the benefit of this disclosure. [0103] As described above, use of a solvent in the liquid hardenable resin component is optional but may be desirable to reduce the viscosity of the hardenable resin component for ease of handling, mixing, and transferring. However, as previously stated, it may be desirable in some embodiments to not 25 use such a solvent for environmental or safety reasons. It is within the ability of one skilled in the art, with the benefit of this disclosure, to determine if and how much solvent is needed to achieve a suitable viscosity. In some embodiments, the amount of the solvent used in the liquid hardenable resin component may be in the range of about 0.1% to about 30% by weight of the liquid hardenable 30 resin component. Optionally, the liquid hardenable resin component may be heated to reduce its viscosity, in place of, or in addition to, using a solvent. [0104] Examples of the hardening agents that can be used in the liquid hardening agent component include, but are not limited to, cyclo-aliphatic amines, such as piperazine, derivatives of piperazine (e~g., 35 aminoethylpiperazine) and modified piperazines; aromatic amines, such as 36 WO 2013/028298 PCT/US2012/047787 methylene dianiline, derivatives of methylene dianiline and hydrogenated forms, and 4,4'-diaminodiphenyl sulfone; aliphatic amines, such as ethylene diamine, diethylene triamine, triethylene tetraamine, and tetraethylene pentaamine; imidazole; pyrazole; pyrazine; pyrimidine; pyridazine; 1H-indazole; purine; 5 phthalazine; naphthyridine; quinoxaline; quinazoline; phenazine; imidazolidine; cinnoline; imidazoline; 1,3,5-triazine; thiazole; pteridine; indazole; amines; polyamines; amides; polyamides; and 2-ethyl-4-rmethyl imidazole; and combinations thereof. The chosen hardening agent often effects the range of temperatures over which a hardenable resin is able to cure. By way of example, 10 and not of limitation, in subterranean formations having a temperature of about 60 IF to about 250 IF, amines and cyclo-aliphatic amines such as piperidine, triethylamine, tris(dimethylaminomethyl) phenol, and dirnethylaminomethyl)phenol rnay be preferred. In subterranean formations having higher temperatures, 4,4'--diaminodiphenyl sulfone may be a suitable 15 hardening agent. Hardening agents that comprise piperazine or a derivative of piperazine have been shown capable of curing various hardenable resins from temperatures as low as about 50 IF to as high as about 350 IF. [0105] The hardening agent used may be included in the liquid hardening agent component in an amount sufficient to at least partially harden 20 the resin composition. In some embodiments of the present invention, the hardening agent used is included in the liquid hardening agent component in the range of about 0.1% to about 95% by weight of the liquid hardening agent component. In other embodiments, the hardening agent used may be included in the liquid hardening agent component in an amount of about 15% to about 25 85% by weight of the liquid hardening agent component. In other embodiments, the hardening agent used may be included in the liquid hardening agent component in an amount of about 15% to about 55% by weight of the liquid hardening agent component. [0106] In some embodiments, the consolidating agent may comprise a 30 liquid hardenable resin component emulsified in a liquid hardening agent component, wherein the liquid hardenable resin component is the internal phase of the emulsion and the liquid hardening agent component is the external phase of the emulsion. In other embodiments, the liquid hardenable resin component may be emulsified in water and the liquid hardening agent component may be 35 present in the water. In other embodiments, the liquid hardenable resin 37 WO 2013/028298 PCT/US2012/047787 component may be emulsified in water and the liquid hardening agent component may be provided separately. Similarly, in other embodiments, both the liquid hardenable resin component and the liquid hardening agent component may both be emulsified in water. 5 [0107] The optional silane coupling agent may be used, among other things, to act as a mediator to help bond the resin to particulates. Examples of suitable silane coupling agents include, but are not limited to, N-2--(aminoethyl) 3-aminopropyltrimethoxysilane, and 3-glycidoxypropyltrimethoxysilane, and combinations thereof. The silane coupling agent may be included in the resin 10 component or the liquid hardening agent component (according to the chemistry of the particular group as determined by one skilled in the art with the benefit of this disclosure). In some embodiments of the present invention, the silane coupling agent used is included in the liquid hardening agent component in the range of about 0.1% to about 3% by weight of the liquid hardening agent 15 component. [0108] Any surfactant compatible with the hardening agent and capable of facilitating the coating of the resin onto particulates in the subterranean formation may be used in the liquid hardening agent component. Such surfactants include, but are not limited to, an alkyl phosphonate surfactant (e.g., 20 a C12-C22 alkyl phosphonate surfactant), an ethoxylated nonyl phenol phosphate ester, one or more cationic surfactants, and one or more nonionic surfactants. Combinations of one or more cationic and nonionic surfactants also may be suitable. Examples of such surfactant combinations are described in U.S. Patent Number 6,311,773, the relevant disclosure of which is incorporated 25 herein by reference. The surfactant or surfactants that may be used are included in the liquid hardening agent component in an amount in the range of about 1% to about 10% by weight of the liquid hardening agent component. [0109] While not required, examples of hydrolyzable esters that may be used in the liquid hardening agent component include, but are not limited to, a 30 combination of dimethylgIutarate, dimethyladipate, and dimethylsuccinate; dirnethylthiolate; methyl salicylate; dimethyl salicylate; and dimethylsuccinate; and combinations thereof. When used, a hydrolyzable ester is included in the liquid hardening agent component in an amount in the range of about 0,1% to about 3% by weight of the liquid hardening agent component. In some 35 embodiments a hydrolyzable ester is included in the liquid hardening agent 38 WO 2013/028298 PCT/US2012/047787 component in an amount in the range of about 1% to about 2.5% by weight of the liquid hardening agent component. [0110] Use of a diluent or liquid carrier fluid in the liquid hardening agent component is optional and may be used to reduce the viscosity of the 5 liquid hardening agent component for ease of handling, mixing, and transferring. As previously stated, it may be desirable in some embodiments to not use such a solvent for environmental or safety reasons. Any suitable carrier fluid that is compatible with the liquid hardening agent component and achieves the desired viscosity effects is suitable for use in the present invention. Some suitable liquid 10 carrier fluids are those having high flash points (e.g., about 125 IF.) because of, among other things, environmental and safety concerns; such solvents include, but are not limited to, butyl lactate, dipropylene glycol methyl ether, dipropylene glycol dimethyl ether, dimethyl formamide, diethyleneglycol methyl ether, ethyleneglycol butyl ether, diethyleneglycol butyl ether, propylene carbonate, 15 methanol, butyl alcohol, d'limonene, and fatty acid methyl esters, and combinations thereof. Other suitable liquid carrier fluids include aqueous dissolvable solvents such as, for example, methanol, isopropanol, butanol, glycol ether solvents, and combinations thereof. Suitable glycol ether liquid carrier fluids include, but are not limited to, diethylene glycol methyl ether, dipropylene 20 glycol methyl ether, 2-butoxy ethanol, ethers of a C2 to C6 dihydric alkanol having at least one C1 to C6 alkyl group, mono ethers of dihydric alkanols, methoxypropanol, butoxyethanol, and hexoxyethanol, and isomers thereof. Combinations of these may be suitable as well. Selection of an appropriate liquid carrier fluid is dependent on, inter alia, the resin composition chosen. 25 [0111] Other resins suitable for use in the present invention are furan based resins. Suitable furan-based resins include, but are not limited to, furfuryl alcohol resins, furfural resins, combinations of furfuryl alcohol resins and aldehydes, and a combination of furan resins and phenolic resins. Of these, furfuryl alcohol resins may be preferred. A furan-based resin may be combined 30 with a solvent to control viscosity if desired. Suitable solvents for use in the furan-based consolidation fluids of the present invention include, but are not limited to, 2-butoxy ethanol, butyl lactate, butyl acetate, tetrahydrofurfuryl methacrylate, tetrahydrofurfuryl acrylate, esters of oxalic, maleic and succinic acids, and furfuryl acetate. Of these, 2--butoxy ethanol is preferred. In some 35 embodiments, the furan-based resins suitable for use in the present invention 39 WO 2013/028298 PCT/US2012/047787 may be capable of enduring temperatures well in excess of 350 OF without degrading. In some embodiments, the furan-based resins suitable for use in the present invention are capable of enduring temperatures up to about 700 IF without degrading. 5 [0112] Optionally, the furan-based resins suitable for use in the present invention may further comprise a curing agent to facilitate or accelerate curing of the furan-based resin at lower temperatures. The presence of a curing agent may be particularly useful in embodiments where the furan-based resin may be placed within subterranean formations having temperatures below about 350 IF, 10 Examples of suitable curing agents include, but are not limited to, organic or inorganic acids, such as, inter alia, maleic acid, fumaric acid, sodium bisulfate, hydrochloric acid, hydrofluoric acid, acetic acid, formic acid, phosphoric acid, sulfonic acid, alkyl benzene sulfonic acids such as toluene sulfonic acid and dodecyl benzene sulfonic acid ("DDBSA"), and combinations thereof. In those 15 embodiments where a curing agent is not used, the furan-based resin may cure autocatalytically. [0113] Still other resins suitable for use in the methods of the present invention are phenolic-based resins. Suitable phenolic-based resins include, but are not limited to, terpolymers of phenol, phenolic formaldehyde resins, and a 20 combination of phenolic and furan resins. In some embodiments, a combination of phenolic and furan resins may be preferred. A phenolic-based resin may be combined with a solvent to control viscosity if desired. Suitable solvents for use in the present invention include, but are not limited to, butyl acetate, butyl lactate, furfuryi acetate, and 2--butoxy ethanol. Of these, 2--butoxy ethanol may 25 be preferred in some embodiments. [0114] Yet another resin-type material suitable for use in the methods of the present invention is a phenol/phenol formaldehyde/furfuryl alcohol resin comprising of about 5% to about 30% phenol, of about 40% to about 70% phenol formaldehyde, of about 10% to about 40% furfuryl alcohol, of about 30 0.1% to about 3% of a silane coupling agent, and of about 1% to about 15% of a surfactant. In the phenol/phenol formaldehyde/furfuryl alcohol resins suitable for use in the methods of the present invention, suitable silane coupling agents include, but are not limited to, N-2-(aminoethy)-3-aminopropyltrimethoxysilane, and 3-glycidoxypropyitrimethoxysilane. Suitable surfactants include, but are not 35 limited to, an ethoxylated nonyl phenol phosphate ester, combinations of one or 40 WO 2013/028298 PCT/US2012/047787 more cationic surfactants, and one or more nonionic surfactants and an alkyl phosphonate surfactant. [0115] In some embodiments, resins suitable for use in the consolidating agent emulsion compositions of the present invention may 5 optionally comprise filler particles. Suitable filler particles may include any particle that does not adversely react with the other components used in accordance with this invention or with the subterranean formation. Examples of suitable filler particles include silica, glass, clay, alumina, fumed silica, carbon black, graphite, rnica, meta-silicate, calcium silicate, calcine, kaoline, talc, 10 zirconia, titanium dioxide, fly ash, and boron, and combinations thereof. In some embodiments, the filler particles may range in size of about 0.01 pm to about 100 pm. As will be understood by one skilled in the art, particles of smaller average size may be particularly useful in situations where it is desirable to obtain high proppant pack permeability (i.e., conductivity), and/or high 15 consolidation strength. In certain embodiments, the filler particles may be included in the resin composition in an amount of about 0.1% to about 70% by weight of the resin composition. In other embodiments, the filler particles may be included in the resin composition in an amount of about 0.5% to about 40% by weight of the resin composition. In some embodiments, the filler particles 20 may be included in the resin composition in an amount of about 1% to about 10% by weight of the resin composition. Some examples of suitable resin compositions comprising filler particles are described in U.S, Patent Publication Number 2008/0006405, the entire disclosure of which is herein incorporated by reference. 25 [0116] Silyl-modified polyamide compounds may be described as substantially self-hardening compositions that are capable of at least partially adhering to particulates in the unhardened state, and that are further capable of self-hardening themselves to a substantially non-tacky state to which individual particulates such as formation fines will not adhere to, for example, in formation 30 or proppant pack pore throats. Such silyl-modified polyamides may be based, for example, on the reaction product of a silating compound with a polyamide or a combination of polyarnides. The polyamide or combination of polyamides may be one or more polyamide intermediate compounds obtained, for example, from the reaction of a polyacid (e.g., diacid or higher) with a polyamine (e.g., diamine or 35 higher) to form a polyamide polymer with the elimination of water. Other 41 WO 2013/028298 PCT/US2012/047787 suitable silyl-modified polyamides and methods of making such compounds are described in U.S. Patent Nurnber 6,439,309, the relevant disclosure of which is herein incorporated by reference. [0117] In other embodiments, the consolidating agent comprises 5 crosslinkable aqueous polymer compositions. Generally, suitable crosslinkable aqueous polymer compositions comprise an aqueous solvent, a crosslinkable polymer, and a crosslinking agent. Such compositions are similar to those used to form gelled treatment fluids, such as fracturing fluids, but according to the methods of the present invention, they are not exposed to breakers or de 10 linkers, and so they retain their viscous nature over time. The aqueous solvent may be any aqueous solvent in which the crosslinkable composition and the crosslinking agent may be dissolved, rnixed, suspended, or dispersed therein to facilitate gel formation. For example, the aqueous solvent used may be freshwater, salt water, brine, seawater, or any other aqueous liquid that does 15 not adversely react with the other components used in accordance with this invention or with the subterranean formation. [0118] Examples of crosslinkable polymers that can be used in the crosslinkable aqueous polymer compositions include, but are not limited to, carboxylate-containing polymers and acrylamide-containing polymers. The most 20 suitable polymers are thought to be those that would absorb or adhere to the rock surfaces so that the rock matrix may be strengthened without occupying a lot of the pore space and/or reducing permeability. Examples of suitable acrylamide-containing polymers include polyacrylamide, partially hydrolyzed polyacrylamide, copolymers of acrylamide and acrylate, and carboxylate 25 containing terpolymers and tetrapolymers of acrylate. Combinations of these may be suitable as well. Additional examples of suitable crosslinkable polymers include hydratable polymers comprising polysaccharides and derivatives thereof, and that contain one or more of the monosaccharide units, galactose, mannose, glucoside, glucose, xylose, arabinose, fructose, glucuronic acid, or pyranosyl 30 sulfate. Suitable natural hydratable polymers include, but are not limited to, guar gum, locust bean gum, tara, konjak, tamarind, starch, cellulose, karaya, xanthan, tragacanth, and carrageenan, and derivatives of all of the above. Combinations of these may be suitable as well. Suitable hydratable synthetic polymers and copolymers that may be used in the crosslinkable aqueous 35 polymer compositions include, but are not limited to, polycarboxylates such as 42 WO 2013/028298 PCT/US2012/047787 polyacrylates and polymethacrylates; polyacrylamides; methylvinyl ether polymers; polyvinyl alcohols; and polyvinylpyrrolidone. Combinations of these may be suitable as well. The crosslinkable polymer used should be included in the crosslinkable aqueous polymer composition in an amount sufficient to form 5 the desired gelled substance in the subterranean formation. In some embodiments of the present invention, the crosslinkable polymer may be included in the crosslinkable aqueous polymer composition in an amount in the range of from about 1% to about 30% by weight of the aqueous solvent. In another embodiment of the present invention, the crosslinkable polymer may be 10 included in the crosslinkable aqueous polymer composition in an amount in the range of from about 1% to about 20% by weight of the aqueous solvent. [0119] The crosslinkable aqueous polymer compositions of the present invention further comprise a crosslinking agent for crosslinking the crosslinkable polymers to form the desired gelled substance. In some embodiments, the 15 crosslinking agent is a molecule or complex containing a reactive transition metal cation. A most preferred crosslinking agent comprises trivalent chromium cations complexed or bonded to anions, atomic oxygen, or water. Examples of suitable crosslinking agents include, but are not limited to, compounds or complexes containing chromic acetate and/or chronic chloride. Other suitable 20 transition metal cations include chromium VI within a redox system, alurninum 111, iron 11, iron 111, and zirconium IV. [0120] The crosslinking agent should be present in the crosslinkable aqueous polymer compositions of the present invention in an amount sufficient to provide, among other things, the desired degree of crosslinking. In some 25 embodiments of the present invention, the crosslinking agent may be present in the crosslinkable aqueous polymer compositions of the present invention in an amount in the range of from about 0.01% to about 5% by weight of the crosslinkable aqueous polymer composition. The exact type and amount of crosslinking agent or agents used depends upon the specific crosslinkable 30 polymer to be crosslinked, formation temperature conditions, and other factors known to those individuals skilled in the art. [0121] Optionally, the crosslinkable aqueous polymer compositions may further comprise a crosslinking delaying agent, such as a polysaccharide crosslinking delaying agent derived from guar, guar derivatives, or cellulose 35 derivatives. The crosslinking delaying agent may be included in the 43 WO 2013/028298 PCT/US2012/047787 crosslinkable aqueous polymer compositions, among other things, to delay crosslinking of the crosslinkable aqueous polymer compositions until desired. One of ordinary skill in the art, with the benefit of this disclosure, will know the appropriate amount of the crosslinking delaying agent to include in the 5 crosslinkable aqueous polymer compositions for a desired application. [0122] In other embodiments, the consolidating agents useful in the methods of the present invention comprise polymerizable organic monomer compositions. Generally, suitable polymerizable organic monomer compositions comprise an aqueous-base fluid, a water-soluble polymerizable organic 10 monomer, an oxygen scavenger, and a primary initiator. [0123] The aqueous-based fluid component of the polymerizable organic monomer composition generally may be freshwater, salt water, brine, seawater, or any other aqueous liquid that does not adversely react with the other components used in accordance with this invention or with the 15 subterranean formation. [0124] A variety of monomers are suitable for use as the water-soluble polymerizable organic monomers in the present invention. Examples of suitable monomers include, but are not limited to, acrylic acid, methacrylic acid, acrylamide, methacrylamide, 2-methacrylamido-2-methylpropane sulfonic acid, 20 dimethylacrylamide, vinyl sulfonic acid, N,N-dimethylaminoethylmethacrylate, 2 triethylammoniumethylmethacrylate chloride, NN-dimethyl aminopropylrnethacryl-amide, methacrylamidepropyltriethylammonium chloride, N-vinyl pyrrolidone, vinyl-phosphonic acid, and methacryloyloxyethyl trimethylammonium sulfate, and combinations thereof. In some embodiments, 25 the water-soluble polymerizable organic monomer should be self-crosslinking. Examples of suitable monomers which are thought to be self crosslinking include, but are not limited to, hydroxyethylacrylate, hydroxymethylacrylate, hydroxyethylrnethacrylate, N-hydroxyrnethylacrylarnide, N-hydroxymethyl methacrylamide, polyethylene glycol acrylate, polyethylene glycol methacrylate, 30 polypropylene gylcol acrylate, and polypropylene glycol methacrylate, and combinations thereof. Of these, hydroxyethylacrylate rnay be preferred in some instances. An example of a particularly suitable monomer is hydroxyethylcellulose-vinyl phosphoric acid. The water-soluble polymerizable organic monomer (or monomers where a combination thereof is used) should be 35 included in the polymerizable organic monomer composition in an amount 44 WO 2013/028298 PCT/US2012/047787 sufficient to form the desired gelled substance after placement of the polymerizable organic monomer composition into the subterranean formation. In some embodiments of the present invention, the water-soluble polymerizable organic monomer may be included in the polymerizable organic monomer 5 composition in an amount in the range of from about 1/b to about 30% by weight of the aqueous-base fluid. In another embodiment of the present invention, the water-soluble polymerizable organic monomer may be included in the polymerizable organic monomer composition in an amount in the range of from about 1% to about 20% by weight of the aqueous-base fluid. 10 [0125] The presence of oxygen in the polymerizable organic monomer composition may inhibit the polymerization process of the water-soluble polymerizable organic monomer or monomers. Therefore, an oxygen scavenger, such as stannous chloride, may be included in the polyrnerizable monomer composition. In order to improve the solubility of stannous chloride so that it 15 may be readily combined with the polymerizable organic monomer composition on the fly, the stannous chloride may be predissolved in a hydrochloric acid solution. For example, the stannous chloride may be dissolved in a 0.1% by weight aqueous hydrochloric acid solution in an amount of about 10% by weight of the resulting solution. The resulting stannous chloride-hydrochloric acid 20 solution may be included in the polymerizable organic monomer composition in an amount in the range of from about 0.1% to about 10% by weight of the polymerizable organic monomer composition. Generally, the stannous chloride may be included in the polyrierizable organic monomer composition of the present invention in an amount in the range of from about 0.005% to about 25 0.1% by weight of the polymerizable organic monomer composition. [0126] A primary initiator may be used, among other things, to initiate polymerization of the water-soluble polymerizable organic monomer(s). Any compound or compounds that form free radicals in aqueous solution may be used as the primary initiator. The free radicals act, among other things, to 30 initiate polymerization of the water-soluble polymerizable organic monomer present in the polyrnerizable organic monomer composition. Compounds suitable for use as the primary initiator include, but are not limited to, alkali metal persulfates; peroxides; oxidation-reduction systems employing reducing agents, such as sulfites in combination with oxidizers; and azo polymerization 35 initiators. Suitable azo polymerization initiators include 2,2'-azobis(2-imidazole 45 WO 2013/028298 PCT/US2012/047787 2-hydroxyethyl) propane, 2,2'-azobis(2-aminopropane), 4,4'-azobis(4 cyanovaleric acid), and 2,2'-azobis(2-rnethyl-N-(2-hydroxyethyl) propionamide. Generally, the primary initiator should be present in the polymerizable organic monomer composition in an amount sufficient to initiate polymerization of the 5 water-soluble polymerizable organic monomer(s). In certain embodiments of the present invention, the primary initiator may be present in the polymerizable organic monomer composition in an amount in the range of from about 0._1% to about 5% by weight of the water-soluble polymerizable organic monomer(s). One skilled in the art, with the benefit of this disclosure, will recognize that as 10 the polymerization temperature increases, the required level of activator decreases. [0127] Optionally, the polymerizable organic monomer compositions further may comprise a secondary initiator. A secondary initiator may be used, for example, where the immature aqueous gel is placed into a subterranean 15 formation that is relatively cool as compared to the surface mixing, such as when placed below the mud line in offshore operations. The secondary initiator may be any suitable water-soluble compound or compounds that may react with the primary initiator to provide free radicals at a lower temperature. An example of a suitable secondary initiator is triethanolamine. In some 20 embodiments of the present invention, the secondary initiator is present in the polymerizable organic monomer composition in an amount in the range of from about 0.1% to about 5% by weight of the water-soluble polyrnerizable organic monomer(s). [0128] Also optionally, the polymerizable organic monomer 25 compositions of the present invention may further comprise a crosslinking agent for crosslinking the polymerizable organic monomer compositions in the desired gelled substance. In some embodiments, the crosslinking agent is a molecule or complex containing a reactive transition metal cation. A suitable crosslinking agent comprises trivalent chromium cations complexed or bonded to anions, 30 atomic oxygen, or water. Examples of suitable crosslinking agents include, but are not limited to, compounds or complexes containing chronic acetate and/or chromic chloride. Other suitable transition metal cations include chromium VI within a redox system, aluminum III, iron II, iron II, and zirconium IV. Generally, the crosslinking agent may be present in polymerizable organic 46 WO 2013/028298 PCT/US2012/047787 monomer compositions in an amount in the range of from 0.01% to about 5% by weight of the polymerizable organic monomer composition. [0129] In some embodiments, a treatment fluid may comprise a base fluid selected from an oil-based fluid, an aqueous-based fluid, a water-in--oil 5 emulsion, or an oil--in-water emulsion. In some embodiments, the base fluid may vary for the different steps described above. In such embodiments, one skilled in the art should understand that a pill may optionally need to be inserted between steps to properly change base fluids. [0130] Suitable oil-based fluids may include an alkane, an olefin, an 10 aromatic organic compound, a cyclic alkane, a paraffin, a diesel fluid, a mineral oil, a desulfurized hydrogenated kerosene, and any combination thereof. Examples of suitable invert emulsions include those disclosed in U.S. Patent Number 5,905,061 5,977,031; and 6,828,279, each of which are incorporated herein by reference. Aqueous base fluids suitable for use in the treatment Fluids 15 of the present invention may comprise fresh water, saltwater (e.g., water containing one or more salts dissolved therein), brine (e.g. saturated salt water), seawater, or combinations thereof. Generally, the water may be from any source, provided that it does not contain components that might adversely affect the stability and/or performance of the first treatment fluids or second treatment 20 fluids of the present invention. In certain embodiments, the density of the aqueous base fluid can be adjusted, among other purposes, to provide additional particulate transport and suspension in the treatment fluids used in the methods of the present invention. In certain embodiments, the pH of the aqueous base fluid may be adjusted (e.g., by a buffer or other pH adjusting agent), among 25 other purposes, to activate a crosslinking agent and/or to reduce the viscosity of the first treatment fluid (e.g., activate a breaker, deactivate a crosslinking agent). In these embodiments, the pH may be adjusted to a specific level, which may depend on, among other factors, the types of gelling agents, acids, and other additives included in the treatment fluid. One of ordinary skill in the 30 art, with the benefit of this disclosure, will recognize when such density and/or pH adjustments are appropriate. [0131] In some embodiments, a treatment fluid for use in the present invention may further comprise an additive including, but not limited to, a salt; a weighting agent; an inert solid; a fluid loss control agent; an emulsifier; a 35 dispersion aid; a corrosion inhibitor; an emulsion thinner; an emulsion thickener; 47 WO 2013/028298 PCT/US2012/047787 a viscosifying agent; a high-pressure, high-temperature emulsifier-filtration control agent; a surfactant; a particulate; a lost circulation material; a foaming agent; a gas; a pH control additive; a breaker; a biocide; a crosslinker; a stabilizer; a chelating agent; a scale inhibitor; a mutual solvent; an oxidizer; a 5 reducer; a friction reducer; a clay stabilizing agent; and any combination thereof. [0132] In some embodiments, the present invention provides for of treating a subterranean formation able to support a fracture network having at least one access conduit to the subterranean formation from a wellbore. 10 Treating the subterranean formation may include the steps, not necessarily in this order or performed independently, placing a first treatment fluid into the subterranean formation through the at least one access conduit at a pressure sufficient to form at least a portion of a fracture network extending frorn the at least one access conduit; pumping a second treatment fluid comprising a 15 propping agent into the fracture network such that the propping agent forms a proppant pack in at least a portion of the fracture network; placing a third treatment fluid comprising a secondary diverting agent into the wellbore such that the secondary diverting agent goes through the access conduit and into at least a portion of the fracture network so as to substantially inhibit fluid flow 20 through at least a portion of the fracture network without substantially inhibiting fluid flow through the access conduit; and placing a fourth treatment fluid comprising a primary diverting agent into the wellbore such that the primary diverting agent substantially inhibits fluid flow through the access conduit. [0133] In some embodiments, the present invention provides for of 25 treating a subterranean formation having a closure pressure greater than about 500 psi and having at least one access conduit to the subterranean formation from a wellbore. Treating the subterranean formation may include the steps, not necessarily in this order or performed independently, placing a first treatment fluid into the subterranean formation through the at least one access 30 conduit at a pressure sufficient to form at least a portion of a fracture network extending from the at least one access conduit; pumping a second treatment fluid comprising a propping agent into the fracture network such that the propping agent forms a proppant pack in at least a portion of the fracture network; placing a third treatment fluid comprising a secondary diverting agent 35 into the wellbore such that the secondary diverting agent goes through the 48 WO 2013/028298 PCT/US2012/047787 access conduit and into at least a portion of the fracture network so as to substantially inhibit fluid flow through at least a portion of the fracture network without substantially inhibiting fluid flow through the access conduit; and placing a Fourth treatment fluid comprising a primary diverting agent into the wellbore 5 such that the primary diverting agent substantially inhibits fluid flow through the access conduit. [0134] In some embodiments, the present invention provides for of treating a subterranean formation able to support a fracture network having at least one access conduit to the subterranean formation from a wellbore. 10 Treating the subterranean formation may include the steps, not necessarily in this order or performed independently, placing a first treatment fluid into the subterranean formation at a pressure sufficient to form at least a portion of a fracture network extending from at least one access conduit; pumping a second treatment fluid comprising a propping agent into the fracture network such that 15 the propping agent forms a proppant pack in at least a portion of the fracture network, wherein the propping agent comprises proppant particulates at least partially coated with a consolidating agent and at least a portion of degradable particles; placing a third treatment fluid comprising a secondary diverting agent into the wellbore such that the secondary diverting agent goes through the 20 access conduit and into at least a portion of the fracture network so as to substantially inhibit fluid flow through at least a portion of the fracture network without substantially inhibiting fluid flow through the access conduit, wherein the secondary diverting agent is at least partially degradable; placing a fourth treatment fluid comprising a primary diverting agent into the wellbore such that 25 the primary diverting agent substantially inhibits fluid flow through the access conduit, wherein the primary diverting agent is at least partially degradable; and repeating at least one step selected from the group consisting of pumping the second treatment fluid, placing the third treatment fluid, placing the fourth treatment fluid, placing the fifth treatment fluid, and any combination thereof. 30 [0135] To facilitate a better understanding of the present invention, the following examples of preferred embodiments are given, In no way should the following examples be read to limit, or to define, the scope of the invention. [0136] Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The 35 particular embodiments disclosed above are illustrative only, as the present 49 WO 2013/028298 PCT/US2012/047787 invention rnay be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. It is therefore 5 evident that the particular illustrative embodiments disclosed above may be altered, combined, or modified and all such variations are considered within the scope and spirit of the present invention. The invention illustratively disclosed herein suitably may be practiced in the absence of any element which is not specifically disclosed herein. While compositions and methods are described in 10 terns of "comprising," "containing," or "including" various components or steps, the compositions and methods can also "consist essentially of" or "consist of" the various components and steps. All numbers and ranges disclosed above may vary by sorne amount. Whenever a numerical range with a lower limit and an upper limit is disclosed, any number and any included range falling within the 15 range is specifically disclosed. In particular, every range of values (of the form, "from about a to about b," or, equivalently, "from approximately a to b," or, equivalently, "from approximately a-b") disclosed herein is to be understood to set forth every number and range encompassed within the broader range of values. Also, the terms in the claims have their plain, ordinary meaning unless 20 otherwise explicitly and clearly defined by the patentee. Moreover, the indefinite articles "a" or "an," as used in the clairns, are defined herein to mean one or more than one of the element that it introduces. If there is any conflict in the usages of a word or term in this specification and one or more patent or other documents that may be incorporated herein by reference, the definitions that are 25 consistent with this specification should be adopted. 50

Claims (23)

1. A method comprising: providing a wellbore penetrating a subterranean formation, wherein the subterranean formation is able to support a fracture network; providing at least one access conduit to the subterranean formation from the wellbore; placing a first treatment fluid into the subterranean formation through at least one access conduit at a pressure sufficient to form at least a portion of a fracture network extending from at least one access conduit; pumping a second treatment fluid comprising a propping agent into the fracture network such that the propping agent forms a proppant pack in at least a portion of the fracture network; placing a third treatment fluid comprising a secondary diverting agent into the wellbore such that the secondary diverting agent goes through the access conduit and into at least a portion of the fracture network so as to substantially inhibit fluid flow through at least a portion of the fracture network without substantially inhibiting fluid flow through the access conduit; and placing a fourth treatment fluid comprising a primary diverting agent into the wellbore such that the primary diverting agent substantially inhibits fluid flow through the access conduit.

2. The method of claim 1 further comprising: producing hydrocarbons from the subterranean formation.

3. The method of claim 1, wherein pumping the second treatment fluid, placing the third treatment fluid, and placing the fourth treatment fluid are performed in any order.

4. The method of claim 1, wherein pumping the second treatment fluid is done continuously while placing the third treatment fluid and placing the fourth treatment fluid.

5. The method of claim 1, wherein the concentration of the propping agent in the second treatment fluid is changed during pumping. 51 WO 2013/028298 PCT/US2012/047787

6. The method of claim 1, wherein a step selected from the group consisting of pumping the second treatment fluid, placing the third treatment fluid, placing the fourth treatment fluid, and any combination thereof are performed more than once.

7. The method of claim 1, wherein the first treatment fluid, the second treatment fluid, the third treatment fluid, and the fourth treatment fluid comprise the same base fluid with different additives.

8. The method of claim 1, wherein the propping agent comprises a proppant particulate coated with a consolidating agent.

9. The method of claim 1, wherein the secondary diverting agent has a diameter of about 150 microns or less.

10. The method of claim 1, wherein the secondary diverting agent is at least partially degradable.

11. The method of claim 1, wherein the primary diverting agent has a bimodal particle size distribution.

12. The method of claim 1, wherein the primary diverting agent comprises first particulates, wherein the secondary diverting agent comprises second particles, and wherein the first particles have a larger average diameter than the second particulates.

13. The method of claim 1, wherein the primary diverting agent comprises perf balls.

14. The method of claim 1, wherein the primary diverting agent comprises a gel.

15. The method of claim 1, wherein the primary diverting agent is at least partially degradable.

16. The method of claim 1 further comprising: introducing a cleanup treatment fluid into the wellbore to enhance fluid flow through at least a portion of the fracture network.

17. The method of claim 1 further comprising: placing a fifth treatment fluid comprising a degradable particle into the fracture network such that the degradable particle is capable of forming voids within at least a portion of the proppant pack. 52 WO 2013/028298 PCT/US2012/047787

18. The method of claim 17, wherein placing a fifth treatment fluid and pumping a second treatment fluid are performed simultaneously.

19. The method of claim 17, wherein the fifth treatment fluid further comprises the propping agent.

20. The method of claim 17 further comprising: introducing a cleanup treatment fluid into the wellbore to enhance fluid flow through at least a portion of the fracture network.

21. The method of claim 17, wherein a step selected from the group consisting of pumping the second treatment fluid, placing the third treatment fluid, placing the fourth treatment fluid, placing a fifth treatment fluid, and any combination thereof is performed more than once.

22. A method comprising: providing a wellbore penetrating a subterranean formation, wherein the subterranean formation has a closure pressure greater than about 500 psi; providing at least one access conduit to the subterranean formation from the wellbore; placing a first treatment fluid into the subterranean formation through the at least one access conduit at a pressure sufficient to form at least a portion of a fracture network extending from the at least one access conduit; pumping a second treatment fluid comprising a propping agent into the fracture network such that the propping agent forms a proppant pack in at least a portion of the fracture network; placing a third treatment fluid comprising a secondary diverting agent into the wellbore such that the secondary diverting agent goes through the access conduit and into at least a portion of the fracture network so as to substantially inhibit fluid flow through at least a portion of the fracture network without substantially inhibiting fluid flow through the access conduit; and placing a fourth treatment fluid comprising a primary diverting agent into the wellbore such that the primary diverting agent substantially inhibits fluid flow through the access conduit.

23. A method comprising: providing a wellbore penetrating a subterranean formation, wherein 53 WO 2013/028298 PCT/US2012/047787 the subterranean formation is able to support a fracture network and the wellbore has at least one access conduit to the subterranean formation from the wellbore; placing a first treatment fluid into the subterranean formation at a pressure sufficient to form at least a portion of a fracture network extending from at least one access conduit; pumping a second treatment fluid comprising a propping agent into the fracture network such that the propping agent forms a proppant pack in at least a portion of the fracture network, wherein the propping agent comprises proppant particulates at least partially coated with a consolidating agent and at least a portion of degradable particles; placing a third treatment fluid comprising a secondary diverting agent into the wellbore such that the secondary diverting agent goes through the access conduit and into at least a portion of the fracture network so as to substantially inhibit fluid flow through at least a portion of the fracture network without substantially inhibiting fluid flow through the access conduit, wherein the secondary diverting agent is at least partially degradable; placing a fourth treatment fluid comprising a primary diverting agent into the wellbore such that the primary diverting agent substantially inhibits fluid flow through the access conduit, wherein the primary diverting agent is at least partially degradable; and repeating at least one step selected from the group consisting of pumping the second treatment fluid, placing the third treatment fluid, placing the fourth treatment fluid, placing the fifth treatment fluid, and any combination thereof. 54